Edgar Filing: OFS Capital Corp

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2013

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

COMMISSION FILE NUMBER: 814-00813

OFS CAPITAL CORPORATION

(Exact name of registrant as specified in its charter)

Delaware

46-1339639

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

2850 West Golf Road, 5th Floor

Rolling Meadows, Illinois 60008

(Address of principal executive office)

(847) 734-2060

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ¨ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	¨	Accelerated filer	¨

Non-accelerated filer	x (do not check if a smaller reporting company)	Smaller reporting company	¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

The number of shares of the issuer’s Common Stock, $0.01 par value, outstanding as of November 4, 2013 was 9,629,797.

OFS CAPITAL CORPORATION

TABLE OF CONTENTS


PART I. FINANCIAL INFORMATION		1
Item 1.	Financial Statements	1
	Consolidated Balance Sheets as of September 30, 2013 (unaudited) and December 31, 2012	1
	Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2013 (unaudited) and 2012 (unaudited)	2
	Consolidated Statements of Changes in Net Assets for the Nine Months Ended September 30, 2013 (unaudited) and September 30, 2012 (unaudited)	3
	Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2013 (unaudited) and 2012 (unaudited)	4
	Consolidated Schedules of Investments as of September 30, 2013 (unaudited) and December 31, 2012	6
	Notes to Unaudited Consolidated Financial Statements	12
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	35
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	50
Item 4.	Controls and Procedures	51

PART II. OTHER INFORMATION		52
Item 1.	Legal Proceedings	52
Item 1A.	Risk Factors	52
Item 2	Unregistered Sales of Equity Securities and Use of Proceeds	53
Item 3.	Defaults Upon Senior Securities	53
Item 4.	Mine Safety Disclosures	53
Item 5.	Other Information	53
Item 6.	Exhibits	53
SIGNATURES		54

Part I - FINANCIAL INFORMATION

Item 1. Financial Statements

OFS Capital Corporation and Subsidiaries

Consolidated Balance Sheets

(Amounts in thousands, except share and per share data)

	September 30,			December 31,
	2013			2012
	(unaudited)
Assets
Investments, at fair value
Non-affiliate investments (cost of $211,661 and $231,781, respectively)	$	207,975		$	227,542
Affiliate investments (cost of $10,115 and $5,049, respectively)		11,322			4,657
Total investments at fair value		219,297			232,199
Cash and cash equivalents		6,835			8,270
Restricted cash and cash equivalents		525			623
Interest receivable		682			1,292
Prepaid expenses and other assets		211			326
Deferred financing costs, net of accumulated amortization of $1,689 and $1,336, respectively		2,036			2,839
Total assets	$	229,586		$	245,549

Liabilities
Accrued professional fees	$	623		$	463
Interest payable		825			1,222
Dividends and distributions payable		3,273			1,628
Management fees payable		831			667
Administration fee payable		200			110
Other payables		219			223
Due to affiliated entities, net		-			9
Deferred loan fee revenue		369			204
Revolving line of credit		84,083			99,224
Total liabilities		90,423			103,750

Net Assets
Preferred stock, par value of $0.01 per share, 2,000,000 shares authorized, 0 shares issued and outstanding as of September 30, 2013 and December 31, 2012		-			-
Common stock, par value of $0.01 per share, 100,000,000 shares authorized, 9,626,987 and 9,578,691 shares issued and outstanding as of September 30, 2013 and December 31, 2012		96			96
Paid-in capital in excess of par		143,092			142,408
Distributions in excess of net investment income		(5,567	)		(94	)
Net unrealized appreciation (depreciation) on investments		1,542			(611	)
Total net assets		139,163			141,799

Total liabilities and net assets	$	229,586		$	245,549

Number of shares outstanding		9,626,987			9,578,691
Net asset value per share	$	14.46		$	14.80

See Notes to Unaudited Consolidated Financial Statements.

OFS Capital Corporation and Subsidiaries

Consolidated Statements of Operations (unaudited)

(Amounts in thousands, except share and per share data)

				Pre-IPO prior to					Pre-IPO prior to
				becoming a					becoming a
				Business					Business
				Development					Development
				Company (1)					Company (1)
	Three Months Ended			Three Months Ended			Nine Months Ended		Nine Months Ended
	September 30, 2013			September 30, 2012			September 30, 2013		September 30, 2012

Investment income
Interest income from non-affiliate investments	$	4,017		$	4,020		$	12,618	$	9,091
Dividend and fee income		-			15			-		106
Total investment income		4,017			4,035			12,618		9,197
Expenses
Interest expense		821			1,511			2,530		2,956
Amortization of deferred financing closing costs		168			144			803		287
Management fees		744			591			2,345		1,555
Management fees - other related parties		-			151			-		627
Professional fees		418			86			1,177		489
Administrative fee		200			-			657		-
General and administrative expenses		238			115			770		493
Total expenses		2,589			2,598			8,282		6,407
Net investment income		1,428			1,437			4,336		2,790
Net realized and unrealized gain (loss) on investments
Net realized gain (loss) on non-affiliate investments		-			(92	)		5		(1,257	)
Net change in unrealized depreciation on non-affiliate investments		(1,501	)		1,173			554		234
Net change in unrealized appreciation on affiliate investments		439			-			1,599		-
Net realized and unrealized gain (loss) on investments		(1,062	)		1,081			2,158		(1,023	)
Other income (loss) prior to becoming a business development company
Income from equity interest in OFS Capital WM		-			-			-		2,645
Income from equity interest in Tamarix LP		-			378			-		378
Net loss attributable to non-controlling interests		-			32			-		61
Other income		-			32			-		29
Total other income prior to becoming a business development company		-			442			-		3,113
Net increase (decrease) in net assets before cumulative effect of accounting change		366			2,960			6,494		4,880
Cumulative effect of accounting change		-			-			-		570
Net increase in net assets resulting from operations	$	366		$	2,960		$	6,494	$	5,450
Net investment income per common share - basic and diluted	$	0.15					$	0.45
Net increase in net assets resulting from operations per common share - basic and diluted	$	0.04					$	0.67
Dividends and distributions declared per common share - basic and diluted	$	0.34					$	1.02
Basic and diluted weighted average shares outstanding		9,626,336						9,616,637

(1) For historical periods that include financial results prior to November 7, 2012, the Company did not have common shares outstanding or an equivalent and, therefore, earnings per share, dividends declared per common shares and weighted average shares outstanding information for periods that include financial results prior to November 7, 2012 are not provided.

See Notes to Unaudited Consolidated Financial Statements.

OFS Capital Corporation and Subsidiaries

Consolidated Statements of Changes in Net Assets (unaudited)

(Amounts in thousands, except share and per share data)

																			Net
													Distributions						Unrealized
											Paid-in		in Excess of						Appreciation
				Non-							Capital in		Net			Accumulated			(Depreciation)
	Member's			Controlling			Common Stock				Excess		Investment			Net Realized			on			Total Net
	Equity			Interests			Shares		Par		of Par		Income			Gain			Investments			Assets

Balance at January 1, 2012	$	54,719		$	-			-	$	-	$	-	$	-		$	-		$	-		$	54,719
Net income		5,450			(61	)		-		-		-		-			-			-			5,389
Member/non-controlling interest contributions		1,227			2,790			-		-		-		-			-			-			4,017
Syndication Costs		(209	)		(121	)		-		-		-		-			-			-			(330	)
Distributions		(6,710	)		(225	)		-		-		-		-			-			-			(6,935	)
Deconsolidation of Tamarix LP adjustment on July 27, 2012
Net income (loss)		-			61			-		-		-		-			-			-			61
Non-controlling interest contributions		-			(2,790	)		-		-		-		-			-			-			(2,790	)
Syndication costs		209			121			-		-		-		-			-			-			330
Distributions		-			225			-		-		-		-			-			-			225
Total deconsolidation of Tamarix LP adjustment		209			(2,383	)		-		-		-		-			-			-			(2,174	)
Balance at September 30, 2012	$	54,686		$	-		$	-	$	-	$	-	$	-		$	-		$	-		$	54,686

Balance at January 1, 2013	$	-		$	-			9,578,691	$	96	$	142,408	$	(94	)	$	-		$	(611	)	$	141,799
Net increase in net assets resulting from operations		-			-			-		-		-		4,336			5			2,153			6,494
Stock issued in connection with dividend reinvestment plan		-			-			48,296		-		684		-			-			-			684
Dividends and distributions		-			-			-		-		-		(9,809	)		(5	)		-			(9,814	)
Balance at September 30, 2013	$	-		$	-			9,626,987	$	96	$	143,092	$	(5,567	)	$	-		$	1,542			139,163

See Notes to Unaudited Consolidated Financial Statements.

OFS Capital Corporation and Subsidiaries

Consolidated Statements of Cash Flows (unaudited)

(Amounts in thousands)

				Pre-IPO prior to
				becoming a
				Business
				Development
				Company
	Nine Months Ended			Nine Months Ended
	September 30, 2013			September 30, 2012

Cash Flows From Operating Activities
Net increase in net assets resulting from operations	$	6,494		$	5,450
Adjustments to reconcile net increase in net assets resulting from operations to net cash provided by operating activities:
Amortization and write-off of deferred financing closing costs		803			287
Amortization of discounts and premium		(972	)		(541	)
Amortization of deferred fee revenue		(88	)		(146	)
Cash collection of deferred fee revenue		253			194
Net realized (gain) loss on non-affiliate investments		(5	)		1,257
Net change in unrealized depreciation on non-affiliate investments		(554	)		(234	)
Net change in unrealized appreciation on affiliate investments		(1,599	)		-
Purchase of portfolio investments		(30,591	)		(34,110	)
Additional equity investment in Tamarix LP		(5,157	)		-
Proceeds from principal payments on portfolio investments		46,976			17,791
Proceeds from sale of portfolio investments to related party		-			4,157
Proceeds from sale of portfolio investments		4,713			-
Income from equity interest in OFS Capital WM		-			(2,645	)
Income from equity interest in Tamarix LP		-			(378	)
Write-off of uncollectible receivables		-			290
Cumulative effect of accounting change		-			(570	)
Net loss allocated to non-controlling interests		-			(61	)
Other income		-			(29	)
Changes in operating assets and liabilities:
Interest receivable		610			(41	)
Accrued paid-in-kind interest		-			(193	)
Prepaid expenses and other assets		207			(14	)
Accrued professional fees		160			-
Due to/from affiliated entities, net		(9	)		211
Interest payable		(397	)		(138	)
Management fees payable		164			18
Management fees payable - other related parties		-			628
Administration fee payable		90			-
Other payables		(5	)		98
Net cash provided (used) by operating activities		21,093			(8,719	)
Cash Flows From Investing Activities
Change in restricted cash		97			-
Advances and other assets		-			(99	)
Distribution from OFS Capital WM		-			1,225
Distribution from Tamarix GP		-			52
Consolidation of cash from OFS Capital WM		-			9,581
Deconsolidation of cash of Tamarix LP		-			(711	)
Net cash provided by investing activities		97			10,048
Cash Flows From Financing Activities
Cash dividends and distributions paid		(7,485	)		-
Net repayments under revolving lines of credit		(15,140	)		6,286
Notes payable due to the SBA		-			14,000
Repayment of advance due to affiliated entities		-			(6,796	)
Distributions to member		-			(2,710	)
Contributions from non-controlling interests		-			2,590
Distributions to non-controlling interests		-			(225	)
Syndication costs		-			(209	)
Syndication costs allocated to non-controlling interests		-			(121	)
Deferred offering costs		-			(361	)
Deferred financing costs		-			(640	)
Net cash provided by (used in) financing activities		(22,625	)		11,814
Net increase (decrease) increase in cash and cash equivalents		(1,435	)		13,143
Cash and cash equivalents — beginning of period		8,270			814
Cash and cash equivalents — end of period	$	6,835		$	13,957

(Continued)

OFS Capital Corporation and Subsidiaries

Consolidated Statements of Cash Flows (unaudited) - continued

(Amounts in thousands)

			Pre-IPO prior to
			becoming a
			Business
			Development
			Company
	Nine Months Ended		Nine Months Ended
	September 30, 2013		September 30, 2012
Supplemental Disclosure of Cash Flow Information:
Cash paid during the period for interest	$	2,927	$	3,092

Supplemental Disclosure of Noncash Financing and Investing Activities:
Accrued deferred offering costs	$	-	$	3,665
Dividends and distributions paid by issuance of common stock		684		-
Dividends and distributions payable		3,273		-
Member distribution payable		-		4,000
Equity contribution from parent recognized due to the difference between the purchase price and fair value of the loan investment purchased from OFS Capital WM		-		1,227
Equity interest received in connection with loan restructuring		-		539
Reclassification of other liabilities to capital contribution from non-controlling interests		-		206
Capital contribution from non-controlling interests via a reduction of management fee payable - related party		-		200
Receivable from investment sold to a related party		-		792
Elimination of equity investment in OFS Capital WM and consolidation of assets and liabilities of OFS Capital WM effective March 30, 2012:
Restricted cash and cash equivalents		-		623
Interest receivable		-		920
Investments, at fair value		-		197,765
Deferred financing costs, net of accumulated amortization		-		2,637
Revolving line of credit - Wells Fargo		-		134,123
Revolving line of credit - Madison Capital		-		30,752
Interest payable		-		1,647
Management fee payable		-		314
Due to affiliated entity		-		18
Accrued expenses and other liabilities		-		132
Deconsolidation of assets and liabilities of Tamarix LP and recording of an equity investment in Tamarix LP under the equity method of accounting effective July 27, 2012:
Interest receivable and other assets		-		240
Investments, at fair value		-		20,109
Deferred financing costs, net of accumulated amortization		-		640
Notes payable due to the SBA		-		14,000
Management fee payable		-		427
Accrued expenses and other liabilities		-		428
Syndication costs		-		(209	)
Non-controlling interests		-		2,383

See Notes to Unaudited Consolidated Financial Statements.

OFS Capital Corporation and Subsidiaries

Consolidated Schedule of Investments (unaudited)

September 30, 2013

(dollar amounts in thousands)

					Spread
Industry		Interest			Above		Principal						Percent of
Name of Portfolio Company	Investment Type	Rate (1)			Index (1)	Maturity	Amount		Cost		Fair Value		Net Assets

Non-affiliate Investments (5)

Aerospace & Defense
Aero-Metric, Inc.	Senior Secured Term Loan		6.75	%	(L +5.50%)	08/27/17	$	2,730	$	2,698	$	2,708		1.9	%
Whitcraft LLC	Senior Secured Term Loan		6.50	%	(L +5.00%)	12/16/15		4,250		4,215		4,225		3.0
								6,980		6,913		6,933		4.9
Automotive
Tectum Holdings Inc (Extang)	Senior Secured Term Loan A		6.50	%	(L +5.25%)	12/03/15		3,053		3,037		3,032		2.2
Trico Products Corporation	Senior Secured Term Loan		6.25	%	(L +4.75%)	07/22/16		4,254		4,217		4,185		3.0
								7,307		7,254		7,217		5.2
Banking, Finance, Insurance & Real Estate
AssuredPartners Capital, Inc.	Senior Secured Term Loan A		5.75	%	(L +4.50%)	12/14/18		4,852		4,852		4,852		3.5
Captive Resources Midco LLC	Senior Secured Term Loan		6.75	%	(L +5.50%)	10/31/18		4,950		4,887		4,881		3.5
CSI Financial Services, LLC (6)	Senior Secured Term Loan		7.25	%	(L +6.00%)	12/07/17		3,379		3,329		3,379		2.4
H.D. Vest, Inc.	Senior Secured Term Loan		5.75	%	(L +4.50%)	12/18/18		4,720		4,687		4,459		3.2
MCMC LLC	Senior Secured Term Loan A		7.50	%	(L +6.00%)	09/30/16		4,108		4,070		4,108		3.0
MYI Acquiror Limited (6)	Senior Secured Term Loan A		6.25	%	(L +4.75%)	09/13/16		4,912		4,865		4,821		3.4
Personable Holdings, Inc.	Senior Secured Term Loan		7.25	%	(L +6.00%)	05/16/18		2,924		2,898		2,898		2.1
Townsend Acquisition LLC	Senior Secured Term Loan		6.25	%	(L +4.75%)	05/18/16		4,474		4,407		4,408		3.2
								34,319		33,995		33,806		24.3
Beverage, Food & Tobacco
Columbus Manufacturing, Inc.	Senior Secured Term Loan B		6.50	%	(L +5.25%)	04/17/18		3,970		3,921		3,903		2.8
Phillips Feed & Pet Supply	Senior Secured Term Loan		6.05	%	(L +4.25%)	10/13/17		3,204		3,174		3,044		2.2
								7,174		7,095		6,947		5.0
Capital Equipment
Dorner MFG, Corp.	Senior Secured Term Loan		6.00	%	(L +4.75%)	06/15/17		3,269		3,221		3,221		2.3
Elgin Fasteners Group	Senior Secured Term Loan		6.00	%	(L +4.75%)	08/26/16		4,876		4,790		4,769		3.4
								8,145		8,011		7,990		5.7
Chemicals, Plastics & Rubber
Actagro, LLC	Senior Secured Term Loan		5.76	%	(L +4.50%)	12/30/16		3,468		3,434		3,360		2.4
Dash Materials LLC	Senior Secured Term Loan		8.75	%	(L +7.50%)	12/26/17		4,874		4,852		4,874		3.5
ICM Products Inc	Senior Secured Term Loan		7.50	%	(L +6.00%)	02/01/17		2,178		2,150		2,178		1.6
Inhance Technologies (f/k/a
Fluoro-Seal International LLC)	Senior Secured Term Loan A		9.00	%	(L +7.50%)	01/04/17		2,611		2,586		2,611		1.9
KODA Distribution Group, Inc.	Senior Secured Term Loan A		7.25	%	(L +5.00%)	04/09/18		3,961		3,943		3,943		2.8
VanDeMark Chemical Inc.	Senior Secured Term Loan		6.50	%	(L +5.25%)	11/30/17		2,902		2,853		2,851		2.0
								19,994		19,818		19,817		14.2
Construction & Building
Jameson LLC	Senior Secured Term Loan		7.52	%	(L +5.50%)	10/01/15		2,069		2,052		2,069		1.5
Royal Adhesives & Sealants, LLC	Senior Secured First Lien Term Loan		5.50	%	(L +4.25%)	07/31/18		4,500		4,456		4,456		3.2
								6,569		6,508		6,525		4.7
Consumer goods: Non-durable
Pacific World	Senior Secured Term Loan		5.75	%	(L +4.75%)	10/31/16		4,694		4,642		4,564		3.3
Phoenix Brands LLC	Senior Secured Term Loan A		8.75	%	(L +7.25%)	01/31/16		3,219		3,191		2,956		2.1
								7,913		7,833		7,520		5.4
Containers, Packaging & Glass
Mold-Rite Plastics, LLC	Senior Secured Term Loan		6.25	%	(L +4.50%)	06/30/16		4,333		4,296		4,262		3.1

Energy: Oil & Gas
ANS Distributing, INC.	Senior Secured Term Loan		8.00	%	(L +6.50%)	11/01/17		3,005		2,956		3,005		2.2
Charter Brokerage LLC	Senior Secured Term Loan A		8.00	%	(L +6.50%)	10/10/16		4,326		4,280		4,326		3.1
Engineered Controls International, LLC	Senior Secured Term Loan		5.75	%	(L +4.50%)	08/05/17		4,347		4,305		4,180		3.0
								11,678		11,541		11,511		8.3
Environmental Industries
Apex Companies, LLC.	Senior Secured Term Loan		6.75	%	(L +5.50%)	12/10/18		3,954		3,921		3,882		2.8
JWC Environmental, LLC.	Senior Secured Term Loan		6.00	%	(L +4.50%)	08/03/16		4,075		4,050		3,976		2.9
								8,029		7,971		7,858		5.7

OFS Capital Corporation and Subsidiaries

Consolidated Schedule of Investments (unaudited) - continued

September 30, 2013

(dollar amounts in thousands)

					Spread
Industry		Interest			Above		Principal								Percent of
Name of Portfolio Company	Investment Type	Rate (1)			Index (1)	Maturity	Amount		Cost			Fair Value			Net Assets

Non-affiliate Investments (5) - continued

Healthcare & Pharmaceuticals
Accelerated Health Systems LLC	Senior Secured Term Loan		5.75	%	(L +4.50%)	07/22/17		4,900		4,867			4,707			3.4	%
Aegis Sciences Corporation	Senior Secured Term Loan A		6.75	%	(L +5.50%)	10/21/16		4,738		4,683			4,707			3.4
Behavioral Health Group	Senior Secured Term Loan A		5.75	%	(L +4.50%)	08/18/16		4,878		4,849			4,739			3.4
Cambridge Major Labs, Inc	Senior Secured Term Loan		6.25	%	(L +5.00%)	12/31/17		3,534		3,436			3,443			2.5
Elements Behavioral Health, Inc.	Senior Secured Term Loan A		7.75	%	(L +6.25%)	08/14/17		4,814		4,759			4,814			3.4
Hygenic Corporation	Senior Secured Term Loan		5.75	%	(L +4.50%)	10/11/18		4,838		4,778			4,576			3.3
MedTech Group, Inc.	Senior Secured Term Loan		6.50	%	(L +5.25%)	09/07/16		4,698		4,656			4,651			3.3
NeuroTherm, Inc	Senior Secured Term Loan		6.50	%	(L +5.00%)	02/01/16		3,793		3,761			3,766			2.7
Strata Pathology Services, Inc. (7)	Senior Secured Term Loan		9.00	%	(L +7.50%)	06/30/16		4,037		3,988			2,081			1.5
Studer Group LLC	Senior Secured Term Loan		6.00	%	(L +4.75%)	07/31/18		3,786		3,751			3,751			2.7
The Ritedose Corporation	Senior Secured Term Loan		7.69	%	(L +6.00%)	11/10/16		3,285		3,250			2,917			2.1
								47,301		46,778			44,152			31.7
High Tech Industries
B&B Electronics Manufacturing Company	Senior Secured Term Loan A		6.50	%	(L +5.00%)	04/04/15		2,763		2,741			2,567			1.8
OnePath Systems, LLC	Senior Secured Term Loan		8.25	%	(L +6.00%)	06/06/17		2,375		2,341			2,375			1.7
								5,138		5,082			4,942			3.5
Media: Advertising, Printing & Publishing
Content Marketing, LLC	Senior Secured Term Loan		7.50	%	(L +6.25%)	12/21/17		3,646		3,600			3,646			2.6
Media Source	Senior Secured Term Loan A		6.78	%	(L +5.25%)	11/07/16		1,246		1,230			1,238			0.9
Media Source	Senior Secured Term Loan B		7.50	%	(L +6.00%)	11/07/16		3,469		3,425			3,469			2.5
Pamarco Technologies, Inc.	Senior Secured Revolver		N/A		(L +3.75%)	12/31/14		-		(5	)		(9	)(2)		-
Pamarco Technologies, Inc.	Senior Secured Term Loan A		6.00	%	(L +3.75%)	12/31/14		2,055		2,049			2,043			1.5
								10,416		10,299			10,387			7.5
Media: Broadcasting & Subscription
Campus Televideo, Inc.	Senior Secured Term Loan		7.25	%	(L +5.75%)	10/23/17		4,394		4,305			4,394			3.2

Retail
Diversified Foodservice Supply, Inc. (f/k/a Consolidated Equipment Parts, Inc.)	Senior Secured Term Loan		6.75	%	(L +5.00%)	01/27/16		4,408		4,376			4,399			3.1
Tharpe Company, Inc.	Senior Secured Term Loan		6.50	%	(L +5.25%)	10/19/17		4,192		4,142			4,122			3.0
								8,600		8,518			8,521			6.1
Services: Business
Revspring Inc. (f/k/a Dantom Systems, Inc.)	Senior Secured Term Loan		6.25	%	(L +5.00%)	08/03/17		4,814		4,782			4,702			3.4
Young Innovations, Inc.	Senior Secured Term Loan A		5.75	%	(L +4.50%)	01/30/19		2,888		2,850			2,850			2.0
								7,702		7,632			7,552			5.4
Telecommunications
Barcodes LLC	Senior Secured Term Loan		7.25	%	(L +6.00%)	11/02/17		3,012		2,975			3,012			2.1
NHR Holdings, LLC	Senior Secured Term Loan A		5.75	%	(L +4.50%)	11/30/18		2,433		2,402			2,299			1.7
NHR Holdings, LLC	Senior Secured Term Loan B		5.75	%	(L +4.50%)	11/30/18		2,467		2,435			2,330			1.7
								7,912		7,812			7,641			5.5

Sub-total Non-affiliate Investments							$	213,904	$	211,661		$	207,975			149.4	%

OFS Capital Corporation and Subsidiaries

Consolidated Schedule of Investments (unaudited) - Continued

September 30, 2013

(dollar amounts in thousands)

										Percent
		Principal								of Net
Name of Portfolio Company	Investment Type	Amount		Cost			Fair Value			Assets

Affiliate Investments

Banking, Finance, Insurance & Real Estate
Tamarix Capital Partners, L.P. (6)	67.5% Limited Partnership Interest		N/A		10,115			11,322			8.1	%
Sub-total Affiliate Investments					10,115			11,322			8.1

Money Market

WF Prime INVT MM #1752 (5)	Money Market		N/A		5,397	⁽³⁾		5,397	⁽³⁾		3.9
WFB Secured Institutional MM (5)	Money Market		N/A		525	⁽⁴⁾		525	⁽⁴⁾		0.4
US Bank Money Market Deposit	Money Market		N/A		811	⁽³⁾		811	⁽³⁾		0.6
Sub-total Money Market					6,733			6,733			4.9

Total Investments (United States)		$	213,904	$	228,509		$	226,030			162.4	%

(1)

The majority of the investments bear interest at a rate that may be determined by reference to LIBOR (L) or Prime and which is reset daily, quarterly or semi-annually. For each investment, we have provided the spread over LIBOR and current interest rate in effect at September 30, 2013. Certain investments are subject to a LIBOR or Prime interest rate floor.

(2)

The negative fair value is the result of the unfunded commitment being valued below par.

(3)

Included in cash and cash equivalents on the consolidated balance sheets.

(4)

Included in restricted cash and cash equivalents on the consolidated balance sheets.

(5)

Pledged as collateral under the OFS Capital WM Credit Facility.

(6)

Indicates assets that the Company deems not "qualifying assets" under Section 55(a) of the Investment Company Act of 1940, as amended. Qualifying assets must represent at least 70% of the Company's total assets at the time of acquisition of any additional non-qualifying assets.

(7)

Non-accrual loan.

See Notes to Unaudited Consolidated Financial Statements.

OFS Capital Corporation and Subsidiaries

Consolidated Schedule of Investments

December 31, 2012

(dollar amounts in thousands)

					Spread
Industry		Interest			Above		Principal						Percent of
Name of Portfolio Company	Investment Type	Rate (1)			Index (1)	Maturity	Amount		Cost		Fair Value		Net Assets

Non-affiliate Investments (5)

Aerospace & Defense
Aero-Metric, Inc.	Senior Secured Term Loan		6.75	%	(L +5.25%)	08/27/17	$	2,819	$	2,780	$	2,737		1.9	%
Whitcraft LLC	Senior Secured Term Loan		6.25	%	(L +4.75%)	12/16/15		4,565		4,514		4,440		3.1
								7,384		7,294		7,177		5.0
Automotive
BBB Industries, LLC	Senior Secured Term Loan		6.50	%	(L +4.50%)	06/29/13		4,713		4,704		4,671		3.3
Tectum Holdings Inc. (Extang)	Senior Secured Term Loan A		7.50	%	(L +5.25%)	12/03/15		3,172		3,149		3,149		2.2
Trico Products Corporation	Senior Secured Term Loan		6.25	%	(L +4.75%)	07/22/16		4,685		4,632		3,798		2.7
								12,570		12,485		11,618		8.2
Banking, Finance, Insurance & Real Estate
AssuredPartners Capital, Inc.	Senior Secured Term Loan A		6.50	%	(L +5.25%)	05/01/18		4,877		4,877		4,651		3.3
Captive Resources Midco LLC	Senior Secured Term Loan		6.75	%	(L +5.50%)	10/31/18		4,987		4,915		4,915		3.5
Cetera Financial Group, Inc.	Senior Secured Term Loan A		6.50	%	(L +5.00%)	06/22/17		4,875		4,854		4,699		3.3
CSI Financial Services, LLC (6)	Senior Secured Term Loan		7.25	%	(L +6.00%)	12/07/17		3,485		3,425		3,425		2.4
Frenkel Benefits LLC	Senior Secured Term Loan A		6.25	%	(L +5.00%)	12/28/15		3,938		3,890		3,831		2.7
H.D. Vest, Inc.	Senior Secured Term Loan		7.00	%	(L +5.50%)	10/03/17		4,813		4,755		4,706		3.3
MCMC LLC	Senior Secured Term Loan A		7.50	%	(L +6.00%)	09/30/16		4,635		4,581		4,627		3.3
MYI Acquiror Limited (6)	Senior Secured Term Loan A		6.25	%	(L +4.75%)	09/13/16		4,962		4,903		4,777		3.4
Personable Holdings, Inc.	Senior Secured Term Loan		8.00	%	(L +6.50%)	05/16/17		3,785		3,745		3,841		2.7
Townsend Acquisition LLC	Senior Secured Term Loan		6.25	%	(L +4.75%)	05/18/16		4,750		4,658		4,598		3.2
								45,107		44,603		44,070		31.1
Beverage, Food and Tobacco
Columbus Manufacturing, Inc.	Senior Secured Term Loan B		6.50	%	(L +5.25%)	04/17/18		4,000		3,942		3,942		2.8
Phillips Feed & Pet Supply	Senior Secured Term Loan		7.50	%	(L +5.25%)	10/13/17		3,265		3,224		3,130		2.2
								7,265		7,166		7,072		5.0
Business Equipment & Services
Dorner MFG, Corp.	Senior Secured Term Loan		6.25	%	(L +4.75%)	06/15/17		3,398		3,338		3,274		2.3
Elgin Fasteners Group	Senior Secured Term Loan		7.00	%	(L +5.50%)	08/26/16		4,695		4,588		4,633		3.3
								8,093		7,926		7,907		5.6
Chemical, Plastics & Rubber
Actagro, LLC	Senior Secured Term Loan		7.00	%	(L +5.50%)	12/30/16		1,950		1,925		1,920		1.4
Inhance Technologies (f/k/a Fluoro-Seal International LLC)	Senior Secured Term Loan A		9.00	%	(L +7.50%)	01/04/17		2,964		2,930		3,024		2.1
ICM Products Inc.	Senior Secured Term Loan		8.50	%	(L +7.00%)	02/01/17		2,406		2,368		2,406		1.7
VanDeMark Chemical Inc.	Senior Secured Term Loan		7.50	%	(L +5.25%)	11/30/17		3,015		2,956		2,956		2.1
								10,335		10,179		10,306		7.3
Construction & Building
Lindstrom Metric, LLC	Senior Secured Term Loan		6.26	%	(L +4.75%)	07/12/16		4,747		4,702		4,586		3.2
Jameson LLC	Senior Secured Term Loan		9.52	%	(L +7.50%)	10/01/15		2,487		2,460		2,240		1.6
Royal Adhesives & Sealants, LLC	Senior Secured Term Loan A		7.25	%	(L +5.50%)	11/29/15		4,498		4,457		4,485		3.1
								11,732		11,619		11,311		7.9
Consumer Goods: Durable
Phillips Plastics	Senior Secured Term Loan		6.50	%	(L +5.00%)	02/12/17		1,707		1,673		1,649		1.2
Revere Industries, LLC	Senior Secured Rollover Loans		9.00	%	(L +6.00%)	06/30/13		1,889		1,891		1,895		1.3
								3,596		3,564		3,544		2.5
Consumer Goods: Non-durable
Pacific World	Senior Secured Term Loan		7.00	%	(L +5.50%)	10/31/16		4,950		4,881		4,879		3.4
Phoenix Brands LLC	Senior Secured Term Loan A		7.00	%	(L +5.50%)	01/31/16		3,781		3,739		3,307		2.3
								8,731		8,620		8,186		5.7

OFS Capital Corporation and Subsidiaries

Consolidated Schedule of Investments - Continued

December 31, 2012

(dollar amounts in thousands)

					Spread
Industry		Interest			Above		Principal								Percent of
Name of Portfolio Company	Investment Type	Rate (1)			Index (1)	Maturity	Amount		Cost			Fair Value			Net Assets

Non-affiliate Investments (5) - Continued

Containers, Packaging & Glass
Mold-Rite Plastics, LLC	Senior Secured Term Loan		6.25	%	(L +4.50%)	06/30/16		4,527		4,477			4,379			3.1

Energy: Oil & Gas
ANS Distributing, INC.	Senior Secured Term Loan		8.00	%	(L +6.50%)	11/01/17		3,250		3,187			3,187			2.2	%
Charter Brokerage LLC	Senior Secured Term Loan A		8.00	%	(L +6.50%)	10/10/16		4,580		4,520			4,652			3.3
Engineered Controls International, LLC	Senior Secured Term Loan		6.50	%	(L +4.75%)	08/05/16		4,362		4,316			4,242			3.0
								12,192		12,023			12,081			8.5
Environmental Industries
Apex Companies, LLC.	Senior Secured Term Loan		7.50	%	(L +5.75%)	12/10/16		4,347		4,302			4,339			3.1
JWC Environmental, LLC.	Senior Secured Term Loan		6.00	%	(L +4.50%)	08/03/16		4,441		4,407			4,245			3.0
								8,788		8,709			8,584			6.1
Healthcare & Pharmaceuticals
Accelerated Health Systems LLC	Senior Secured Term Loan		7.25	%	(L +5.75%)	07/22/17		4,950		4,911			4,896			3.5
Aegis Sciences Corporation	Senior Secured Term Loan A		7.00	%	(L +5.50%)	10/21/16		4,850		4,781			4,779			3.4
Behavioral Health Group	Senior Secured Term Loan A		5.75	%	(L +4.50%)	08/18/16		4,938		4,900			4,699			3.3
Elements Behavioral Health, Inc.	Senior Secured Term Loan A		7.50	%	(L +6.00%)	08/14/17		4,938		4,870			4,920			3.5
Hygenic Corporation	Senior Secured Term Loan		6.25	%	(L +5.00%)	10/11/18		5,000		4,928			4,928			3.5
MedTech Group, Inc.	Senior Secured Term Loan		7.00	%	(L +5.50%)	09/07/16		4,808		4,755			4,740			3.3
NeuroTherm, Inc.	Senior Secured Term Loan		6.50	%	(L +5.00%)	02/01/16		4,529		4,478			4,326			3.1
Strata Pathology Services, Inc.	Senior Secured Term Loan		8.00	%	(L +6.50%)	06/30/16		4,874		4,811			4,202			3.0
Studer Group LLC	Senior Secured Term Loan		7.00	%	(L +5.50%)	09/28/16		4,604		4,551			4,538			3.2
The Ritedose Corporation	Senior Secured Term Loan		6.50	%	(L +4.75%)	11/10/16		3,592		3,545			2,881			2.0
								47,083		46,530			44,909			31.8
High Tech Industries
B&B Electronics Manufacturing	Senior Secured Term Loan A		6.50	%	(L +5.00%)	04/04/15		2,905		2,870			2,858			2.0
OnePath Systems, LLC	Senior Secured Term Loan		7.50	%	(L +6.00%)	06/06/17		2,438		2,395			2,431			1.7
								5,343		5,265			5,289			3.7
Media: Advertising, Printing & Publishing
Media Source	Senior Secured Term Loan A		6.75	%	(L +5.25%)	11/07/16		1,322		1,301			1,293			0.9
Media Source	Senior Secured Term Loan B		7.50	%	(L +6.00%)	11/07/16		3,496		3,440			3,502			2.5
Pamarco Technologies, Inc.	Senior Secured Revolver		N/A		(L +3.75%)	12/31/14		-		(8	)		(33	)(2)		-
Pamarco Technologies, Inc.	Senior Secured Term Loan A		6.00	%	(L +3.75%)	12/31/14		2,885		2,871			2,821			2.0
								7,703		7,604			7,583			5.4
Media: Broadcasting & Subscription
Campus Televideo, Inc. (f/k/a Lamont Digital Systems, Inc.)	Senior Secured Term Loan		7.25	%	(L +5.75%)	10/23/17		4,661		4,549			4,549			3.2

Retail
Diversified Foodservice Supply, Inc. f/k/a
Consolidated Equipment Parts, Inc.	Senior Secured Term Loan		6.75	%	(L +5.00%)	01/27/16		4,580		4,536			4,508			3.2
Tharpe Company, Inc.	Senior Secured Term Loan		7.00	%	(L +5.75%)	10/19/17		5,000		4,928			4,928			3.5
								9,580		9,464			9,436			6.7
Services: Business
Kellermeyer Building Services, LLC	Senior Secured Term Loan		6.50	%	(L +4.75%)	12/17/15		4,609		4,546			4,511			3.2
Revspring Inc. (f/k/a Dantom Systems, Inc.)	Senior Secured Term Loan		6.25	%	(L +5.00%)	08/03/17	$	4,907	$	4,868		$	4,673			3.3
								9,516		9,414			9,184			6.5
Telecommunications
Barcodes LLC	Senior Secured Term Loan		7.25	%	(L +6.00%)	11/02/17		3,089		3,044			3,044			2.1
ConvergeOne Holdings Corporation	Senior Secured Term Loan A		8.50	%	(L +7.00%)	06/08/17		2,340		2,320			2,387			1.7
NHR Holdings, LLC	Senior Secured Term Loan A		6.50	%	(L +5.25%)	11/30/18		2,483		2,446			2,446			1.7
NHR Holdings, LLC	Senior Secured Term Loan B		6.50	%	(L +5.25%)	11/30/18		2,517		2,480			2,480			1.7
								10,429		10,290			10,357			7.2

Sub-total Non-affiliate Investments							$	234,635	$	231,781		$	227,542			160.5	%

OFS Capital Corporation and Subsidiaries

Consolidated Schedule of Investments - Continued

December 31, 2012

(dollar amounts in thousands)

										Percent
		Principal								of Net
Name of Portfolio Company	Investment Type	Amount		Cost			Fair Value			Assets

Affiliate Investments

Banking, Finance, Insurance & Real Estate
Tamarix Capital Partners, L.P. (6)	67.5% Limited Partnership Interest		N/A		5,049			4,657			3.3	%
Sub-total Affiliate Investments					5,049			4,657			3.3

Money Market

WF Prime INVT MM #1752 (5)	Money Market		N/A		2,450	⁽³⁾		2,450	⁽³⁾		1.7
WFB Secured Institutional MM (5)	Money Market		N/A		623	⁽⁴⁾		623	⁽⁴⁾		0.5
US Bank Money Market Deposit	Money Market		N/A		3,030	⁽³⁾		3,030	⁽³⁾		2.1
Sub-total Money Market					6,103			6,103			4.3

Total Investments (United States)		$	234,635	$	242,933		$	238,302			168.1	%

(1) The majority of the investments bear interest at a rate that may be determined by reference to LIBOR (L) or Prime and which is reset daily, quarterly or semi-annually. For each investment, we have provided the spread over LIBOR and current interest rate in effect at Decembert 31, 2012. Certain investments are subject to a LIBOR or Prime interest rate floor.

(2)

The negative fair value is the result of the unfunded commitment being valued below par.

(3)

Included in cash and cash equivalents on the consolidated balance sheets.

(4)

Included in restricted cash and cash equivalents on the consolidated balance sheets.

(5)

Pledged as collateral under the OFS Capital WM Credit Facility.

(6)

OFS Capital Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

(Amounts in thousands, except share and per share data)

Note 1.

Organization

OFS Capital Corporation (“OFS Capital”, the “Company”, or “we”) is a Delaware corporation formed on November 7, 2012 and is an externally managed, closed-end, non-diversified management investment company. The Company has elected to be treated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). In addition, for tax purposes, the Company has elected to be treated as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

From time to time, the term OFS Capital, the Company, or we may be used herein to refer to OFS Capital Corporation, individually, or OFS Capital Corporation and/or its subsidiaries either collectively or individually, as well as, with respect to all periods prior to the initial public offering (“IPO”) date, OFS Capital, LLC.

On November 7, 2012, the Company priced its IPO, selling 6,666,667 shares of its common stock at a public offering price of $15 per share and raising $100 million in gross proceeds. Immediately prior to the IPO, on November 7, 2012, OFS Capital, LLC converted from a limited liability company to a corporation, as a result of which the sole membership interest held in OFS Capital, LLC by Orchard First Source Asset Management, LLC (“OFSAM”) prior to the conversion was exchanged for 2,912,024 shares of common stock in the Company.

On September 28, 2010, OFS Capital, LLC became the 100% equity owner of OFS Capital WM, LLC (“OFS Capital WM”). On September 29, 2011, OFS Capital, LLC became the primary beneficiary in Tamarix Capital Partners, LP (“Tamarix LP”), a variable interest entity (“VIE”) under the applicable provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 810, “Consolidation” (ASC Topic 810). On May 10, 2012, upon Tamarix LP’s receipt of a Small Business Investment Company (“SBIC”) license, OFS Capital, LLC became an approximately 68% limited partner in Tamarix LP (see Note 4 for more detail).

The Company’s investment strategy is to invest primarily in senior secured debt investments to middle-market companies and, to a lesser extent, junior capital, including mezzanine debt and preferred and common equity. The Company has entered into an investment advisory and management agreement with OFS Capital Management, LLC (the “Investment Advisor”), under which the Investment Advisor manages the day-to-day operations of, and provides investment advisory services to, the Company (see Note 5 for more detail).

Note 2.

Summary of Significant Accounting Policies

Election to become a Business Development Company: The results of operations for the three and nine months ended September 30, 2013 reflect the Company’s results as a BDC under the 1940 Act, whereas the operating results for the three and nine months ended September 30, 2012 reflect the Company’s results prior to operating as a BDC under the 1940 Act. Accounting principles used in the preparation of these two periods are different and, therefore, the financial position and results of operations for those periods are not directly comparable. The primary difference in accounting principles relates to the carrying value of debt and equity investments.

Basis of presentation: The accompanying interim consolidated financial statements of the Company and related financial information have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Article 6 or 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for annual financial statements. In the opinion of management, the consolidated financial statements reflect all adjustments consisting only of normal recurring accruals and adjustments except: (1) OFS Capital’s consolidation of the financial statements of OFS Capital WM effective March 30, 2012 (see Note 3); (2) the cumulative effect of accounting change to convert from cost to fair value accounting of Tamarix LP’s portfolio investments effective May 10, 2012 as a result of Tamarix LP’s receipt of the SBIC license and conversion to an investment company (see “Cumulative effect of accounting change prior to Tamarix LP becoming an investment company” section below); and (3) deconsolidation of the financial statements of Tamarix LP effective July 27, 2012 (see Note 4), which adjustments are, in the opinion of management, necessary to fairly state the operating results for the respective periods. All intercompany balances and transactions have been eliminated. Certain prior period amounts have been reclassified to conform to the current period presentation.

Principles of consolidation: The Company’s September 30, 2013 consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, OFS Capital WM and OFS Funding, LLC. The Company consolidates an affiliated subsidiary if it owns more than 50 percent of the subsidiary’s equity and holds the controlling financial interest in such subsidiary. The Company also consolidates a VIE if it is the primary beneficiary in the VIE. Effective March 30, 2012, the Company consolidated the financial statements of OFS Capital WM into its own (see Note 3). Effective July 27, 2012, the Company deconsolidated the financial statements of Tamarix LP from its own (see Note 4).

OFS Capital Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

(Amounts in thousands, except share and per share data)

Note 2. Summary of Significant Accounting Policies (Continued)

Cumulative effect of accounting change prior to Tamarix LP becoming an investment company: Equity contributions made by potential investors in Tamarix LP prior to issuance of the SBIC license on May 10, 2012 were contingent upon receipt of the SBIC license, and were fully refundable in the event that Tamarix LP failed to obtain such license. As a result, prior to May 10, 2012, Tamarix LP was not deemed to be an investment company and accordingly, followed the same accounting principles as its primary beneficiary, OFS Capital, to account for its loans receivable at cost and its equity interests under the cost method of accounting on the consolidated financial statements of OFS Capital. On May 10, 2012, upon receipt of the SBIC license, Tamarix LP was deemed to be an investment company under Accounting Standards Codification 946, “Financial Services – Investment Companies” (“ASC Topic 946”), and began reporting its investment assets at fair value. Accordingly, effective May 10, 2012, Tamarix LP changed its accounting principle from cost to fair value for measuring its portfolio investments, and recorded a cumulative effect of this accounting change in the amount of $570 to reflect the difference between the fair value and cost basis of its portfolio investments at May 10, 2012.

The cumulative effect of the accounting change at May 10, 2012 reflects the effect of Tamarix LP’s conversion to an investment company as follows:

Cumulative Effect of Conversion to an Investment Company

Effect of recording loans at fair value	$	211
Effect of recording equity investments at fair value		140
Elimination of allowance for loan losses		219
	$	570

Fair value of financial instruments: The Company applies fair value to substantially all of its financial instruments in accordance with Accounting Standards Codification Topic 820, “Fair Value Measurements and Disclosures” (“ASC Topic 820”). ASC Topic 820 defines fair value, establishes a framework used to measure fair value and requires disclosures for fair value measurements. In accordance with ASC Topic 820, the Company has categorized its financial instruments carried at fair value, based on the priority of the valuation technique, into a three level fair value hierarchy. Fair value is a market-based measure considered from the perspective of the market participant that holds the financial instrument rather than an entity specific measure. Therefore, when market assumptions are not readily available, the Company’s own assumptions reflect those that management believes market participants would use in pricing the financial instrument at the measurement date.

The availability of observable inputs can vary depending on the financial instrument and is affected by a wide variety of factors, including, for example, the type of product, whether the product is new, whether the product is traded on an active exchange or in the secondary market, and the current market conditions. To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for financial instruments classified as Level 3 (i.e., those instruments valued using non-observable inputs).

Changes to the valuation policy are reviewed by management and the Company’s board of directors (the “Board”) to confirm that the changes are justified. As markets change, new products develop and the pricing for products becomes more or less transparent, the Company will continue to refine its valuation methodologies.

Use of estimates: The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

OFS Capital Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

(Amounts in thousands, except share and per share data)

Note 2. Summary of Significant Accounting Policies (Continued)

Reporting segments: In accordance with segment guidance set by Accounting Standards Codification 280, “Segment Reporting” (“ASC Topic 280”), the Company has determined that it has a single reporting segment and operating unit structure.

Cash and cash equivalents: Cash and cash equivalents consist of cash and highly liquid investments not held for resale with original maturities at the time of acquisition of three months or less. The Company places its cash in financial institutions and at times, such balances may be in excess of the Federal Deposit Insurance Corporation insurance limits.

Restricted cash and cash equivalents: Restricted cash and cash equivalents represent amounts maintained in the Unfunded Exposure Account of OFS Capital WM as defined by the Loan Sale Agreement and other applicable transaction documents and are subject to the lien of the trustee for the benefit of the secured parties of OFS Capital WM. Proceeds in the Unfunded Exposure Account, along with advances under the OFS Capital WM Credit Facility (see Note 9), are utilized to fund an eligible loan owned by OFS Capital WM that has an unfunded revolving commitment.

Investments and related investment income: Investments are recorded at fair value. The Company’s Board determines the fair value of its portfolio investments. The determination of the fair value of the portfolio investments includes an analysis of the value of any unfunded loan commitments. Interest income is accrued based upon the outstanding principal amount and contractual interest terms of debt investments. The Company accrues interest income until certain events take place, which may place a loan into a non-accrual status. Premiums, discounts and origination fees are amortized or accreted into interest income over the life of the respective debt investment. As of September 30, 2013 and December 31, 2012, unamortized discounts and origination fees on debt investments amounted to $2,244 and $2,854, respectively. For the three and nine months ended September 30, 2013, the Company recognized net loan origination fee income of $335 and $1,060, respectively. For the three and nine months ended September 30, 2012, the Company recognized net loan origination fee income of $206 and $687, respectively.

For investments with contractual payment-in-kind interest (“PIK”), which represents contractual interest accrued and added to the principal balance that generally becomes due at maturity (or at some other stipulated date), the Company will not accrue PIK interest if the portfolio company valuation indicates that the PIK interest is not collectible. For the three and nine months ended September 30, 2013, the Company did not recognize any PIK interest. For the three and nine months ended September 30, 2012, the Company recognized PIK interest in the amount of $99 and $193, respectively. Investment transactions are accounted for on a trade-date basis. Realized gains or losses on investments are measured by the difference between the net proceeds from the disposition and the cost basis of investment, without regard to unrealized gains or losses previously recognized. The Company reports changes in fair value of investments that are measured at fair value as a component of the net changes in unrealized depreciation on non-affiliate investments or unrealized appreciation on affiliate investments in the consolidated statement of operations.

Non-accrual loans: Loans on which the accrual of interest income has been discontinued are designated as non-accrual loans, and non-accrual loans are further designated to be accounted for under either a non-accrual cash method or a non-accrual cost recovery method. Loans are generally placed on non-accrual when a loan either: (i) is delinquent for 90 days or more on principal or interest based on contractual terms of the loan (unless well secured and in the process of collection), or (ii) in the opinion of the Company’s management, there is reasonable doubt about the collectability. When loans are placed on non-accrual status, all interest previously accrued but not collected is reversed against current period interest income. Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management’s judgment. Interest accruals are resumed on non-accrual loans only when they are brought current with respect to interest and principal and when, in the judgment of management, the loans are estimated to be fully collectible as to all principal and interest. There was one non-accrual loan with a fair value of $2,081 at September 30, 2013. There were no non-accrual loans at December 31, 2012.

Allowances for loan losses: Prior to the Company’s election to become a BDC, the allowance for loan losses represented management’s estimate of probable losses inherent in the loan portfolio as of the balance sheet date. When determining the adequacy of the allowance for loan losses, the following factors were considered: historical internal experience and current industry conditions, economic conditions and trends, credit quality trends and other factors deemed relevant. Additions to the allowance were charged to current period earnings through the provision for loan losses. Periodically, management might have determined that it was appropriate to charge-off a portion of an existing loan. Upon the resolution of a loan that had remaining outstanding amounts that had been reserved for and were determined to be uncollectible, such amounts were charged off directly against the allowance for loan losses. To the extent that an amount was not reserved for, then this amount was charged off through the provision for loan losses on the consolidated statement of operations.

OFS Capital Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

(Amounts in thousands, except share and per share data)

Note 2. Summary of Significant Accounting Policies (Continued)

Income taxes: The Company has elected to be treated as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to qualify as a RIC, among other things, the Company is required to meet certain source of income and asset diversification requirements and timely distribute to its stockholders at least 90% of investment company taxable income, as defined by the Code, for each year. The Company has made, and intends to continue to make, the requisite distributions to its stockholders, which will generally relieve the Company from U.S. federal income taxes with respect to all income distributed to its stockholders.

Depending on the level of taxable income earned in a tax year, the Company may choose to retain taxable income in excess of current year dividend distributions into the next tax year in an amount less than what would trigger payments of federal income tax under subchapter M of the Code. The Company would then pay a 4% excise tax on such income, as required. To the extent that the Company determines its estimated current year annual taxable income may exceed estimated current year dividend distributions, the Company accrues excise tax on estimated excess taxable income as taxable income is earned. At September 30, 2013, no U.S. federal excise tax was accrued. At December 31, 2012, the Company accrued $63 of U.S. federal excise tax, which was paid in March 2013.

The Company accounts for income taxes in conformity with Accounting Standards Codification 740, “Income Taxes” (“ASC Topic 740”). ASC Topic 740 provides guidelines for how uncertain tax positions should be recognized, measured, presented and disclosed in financial statements. ASC Topic 740 requires the evaluation of tax positions taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority. Tax benefits of positions not deemed to meet the more-likely-than-not threshold would be recorded as a tax expense in the current year. It is the Company’s policy to recognize accrued interest and penalties related to uncertain tax benefits in income tax expense. There were no material uncertain income tax positions at September 30, 2013 and December 31, 2012. The current and prior three tax years remain subject to examination by U.S. federal and most state tax authorities.

Prior to the Company’s election to become a BDC, the Company, as a limited liability company, did not record a provision for federal income taxes or deferred tax benefits because its income was taxable to its members. Therefore, no federal or state income tax provision had been recorded for the three and nine months ended September 30, 2012.

Dividends and distributions: Dividends and distributions to common stockholders are recorded on the declaration date. The amount to be paid out as a dividend or distribution is determined by the Board each quarter and is generally related to the earnings estimated by management. Net realized capital gains, if any, are distributed at least annually, although the Company may decide to retain such capital gains for investment.

The Company has adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of any distributions the Company declares in cash on behalf of its stockholders, unless a stockholder elects to receive cash. As a result, if the Board authorizes and the Company declares a cash distribution, then stockholders who have not “opted out” of the DRIP will have their cash distribution automatically reinvested in additional shares of the Company’s common stock, rather than receiving the cash dividend or distribution.

The Company may use newly issued shares under the guidelines of the DRIP, or the Company may purchase shares in the open market in connection with its obligations under the plan.

Deferred offering costs: The Company defers costs related to its public offerings until completion of the offerings. These costs include professional fees, registration costs, printing, and other miscellaneous offering costs. Deferred offering costs are charged against the proceeds from equity offerings when received.

Deferred financing closing costs: Deferred financing costs represent fees and other direct incremental costs incurred in connection with the Company’s borrowings. These amounts are amortized over the estimated average life of the borrowings. As of September 30, 2013 and December 31, 2012, unamortized deferred financing costs recorded by the Company amounted to $2,036 and $2,839, respectively. For the three and nine months ended September 30, 2013, the Company recorded amortization expense of $168 and $803, respectively, on its deferred financing costs. For the three and nine months ended September 30, 2012, the Company recorded amortization expense of $144 and $287, respectively, on its deferred financing costs.

OFS Capital Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

(Amounts in thousands, except share and per share data)

Note 2. Summary of Significant Accounting Policies (Continued)

Equity investments: Historically, the Company had received various equity ownership interests from its borrowers as partial consideration for loan modifications or restructurings or from exercising its rights under various loan documents. The Company applied foreclosure accounting and recorded these equity interests at fair value at the time of the loan restructurings. Prior to the Company’s election to become a BDC, equity interests were reviewed subsequently for potential impairment. There were none of these types of equity interests at September 30, 2013 and December 31, 2012.

In connection with certain lending arrangements, the Company may receive warrants to purchase shares of stock from the borrowers. Because the warrant agreements typically contain net exercise or “cashless” exercise provisions, the warrants qualify as derivative instruments under Accounting Standards Codification 815, “Derivatives and Hedging” (“ASC Topic 815”). Such warrants are considered loan fees and are recorded as unearned loan income on the grant date. The unearned income is recognized as interest income over the contractual life of the related loan in accordance with the Company’s income recognition policy. As such warrants held are deemed to be derivative, they are periodically measured at fair value. Any adjustment to fair value is recorded through earnings as net unrealized gain or loss on warrants. For the three and nine months ended September 30, 2013 and 2012, the Company did not recognize any unrealized gain or loss on warrants.

For the three months ended March 31, 2012, under the equity method of accounting, the Company’s 100% share of the net income or loss of OFS Capital WM was included in “Income from equity interest in OFS Capital WM” in the consolidated statements of operations. Commencing with the execution of the WM 2012 Loan Amendment, effective April 1, 2012, OFS Capital consolidated the statement of operations of OFS Capital WM into its own (see Note 3).

In September and November 2011, in connection with its loan originations, Tamarix LP received a 14.9% LLC membership interest in one borrower and a 19.8% preferred stock ownership interest in another borrower which were valued at $500 and $1,955, respectively, at the date of the respective loan origination. The Company applied the cost method of accounting to these equity interests until May 10, 2012, when Tamarix LP became an investment company and adopted fair value accounting on its portfolio investments.

Effective July 27, 2012, the Company deconsolidated the financial statements of Tamarix LP from its own, and adopted the equity method of accounting to account for its investment in Tamarix LP (see Note 4) through November 7, 2012. Accordingly, commencing July 27, 2012 through November 7, 2012, the Company’s share of the net income or loss of Tamarix LP was included in “Income from equity interest in Tamarix LP” in the consolidated statement of operations under the equity method of accounting. Commencing November 8, 2012, upon the Company’s election to become a BDC, the Company accounts for its equity investment in Tamarix LP at fair value.

Interest expense: Interest expense is recognized on the accrual basis.

Syndication costs: Costs incurred in the private placement offering of Tamarix LP’s interests were charged against the partners’ capital as incurred.

Organizational costs: Costs incurred in organizing Tamarix LP were expensed as incurred and are included in general and administrative expenses on the Company’s consolidated statement of operations.

Concentration of credit risk: Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash deposits at financial institutions. At various times during the year, the Company may exceed the federally insured limits. To mitigate this risk, the Company places cash deposits only with high credit quality institutions. Management believes the risk of loss is minimal.

Recent accounting pronouncements: In June 2013, the FASB issued ASU 2013-08, Financial Services – Investment Companies (Topic 946): Amendments to the Scope, Measurement, and Disclosure Requirements (ASU 2013-08), which amends the criteria that define an investment company, clarifies the measurement guidance and requires new disclosures for investment companies. Under ASU 2013-08, an entity already regulated under the 1940 Act is automatically an investment company under the new GAAP definition, so we anticipate no impacts from adopting this standard on our financial position or results of operations. We are currently assessing the additional disclosure requirements. ASU 2013-08 is effective for interim and annual reporting periods in fiscal years that begin after December 15, 2013.

OFS Capital Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

(Amounts in thousands, except share and per share data)

Note 3. OFS Capital WM

Consolidation of OFS Capital WM

OFS Capital WM is a wholly owned subsidiary of OFS Capital formed in August 2010 with the limited purpose of holding, acquiring, managing and financing senior secured loan investments to middle-market companies in the United States. Prior to March 30, 2012, the Company determined that OFS Capital WM was a VIE of OFS Capital under the applicable provisions of ASC Topic 810. OFS Capital, as the owner of 100% of the equity of OFS Capital WM, has the obligation to absorb losses and the right to receive benefits, either of which could be significant to OFS Capital WM. However, prior to March 30, 2012, despite its 100% equity interest in OFS Capital WM, OFS Capital was not the primary beneficiary of OFS Capital WM as OFS Capital lacked the power, through voting interests or similar rights, to direct the activities of OFS Capital WM that most significantly impact its economic performance. The Company had concluded that MCF Capital Management, LLC (the “Loan Manager”) was the primary beneficiary of OFS Capital WM, because (1) under the terms of the loan facility of OFS Capital WM, the Loan Manager had the sole authority to service, administer and exercise rights and remedies in respect of the assets in OFS Capital WM’s portfolio; (2) the Loan Manager had the sole authority to determine whether to cause assets to be sold or acquired by OFS Capital WM, subject to certain limited circumstances where the Company had consent rights, as administrative manager of OFS Capital WM; (3) OFS Capital, as the administrative manager of OFS Capital WM, carried out duties of OFS Capital WM primarily limited to administrative matters, and (4) for its service, the Loan Manager receives a fee. The Company had determined the Loan Manager’s right to receive a loan management fee from OFS Capital WM, the interest of its related party in the class B loans of OFS Capital WM, and the implicit financial responsibility of the Loan Manager to ensure the VIE operated as designed were significant to OFS Capital WM. Since the Loan Manager was the primary beneficiary of OFS Capital WM, prior to March 30, 2012, the Company did not consolidate the financial statements of OFS Capital WM but instead accounted for its ownership interest under the equity method of accounting.

Through March 30, 2012, OFS Capital WM’s loan portfolio was essentially fully funded, which makes future management activities a critical component to ensure satisfactory credit quality and profitability of OFS Capital WM’s loan portfolio. Effective March 30, 2012, OFS Capital entered into an agreement with OFS Capital WM and the Loan Manager to amend the credit facility of OFS Capital WM (WM 2012 Loan Amendment), as a result of which, (1) instead of the Loan Manager having the sole authority to determine actions on any proposed amendment, modification, restructuring, and waiver of loans, the Loan Manager is required to consult with OFS Capital before taking any such actions with a borrower, (2) instead of the Loan Manager having the sole authority to call or waive any default with respect to any loan, the Loan Manager is required to consult with OFS Capital before taking any such actions with a borrower, and (3) instead of the Loan Manager having the sole authority to vote to accelerate the maturity of any loan, the Loan Manager is required to consult with OFS Capital before taking any such actions with a borrower. If OFS Capital indicates in writing that it is dissatisfied with any actions in respect of the foregoing ultimately taken by the Loan Manager, pursuant to the WM 2012 Loan Amendment, the Loan Manager may pursue the course of action that it has recommended; however, the Loan Manager will also be obligated to promptly engage a third party broker/dealer to sell the loan in question, with OFS Capital possessing the sole right to negotiate and approve the terms of any such sale transaction (including price), as well as the sole right to terminate any loan sale discussions and to block any prospective loan sale. In consideration for the rights received as a result of the WM 2012 Loan Amendment, OFS Capital agreed to give up a right of first refusal that it possessed with respect to future transactions substantially similar to the September 28, 2010 loan sale transaction OFS Capital conducted with OFS Capital WM that the Loan Manager and/or its affiliates may seek to conduct with third parties.

The WM 2012 Loan Amendment granted OFS Capital significant participating rights. Additionally, owing to: (1) the significant repayment since September 28, 2010 of the preponderant portion of the loans transferred to OFS Capital WM on that date and over which OFS Capital did not have the right to consent to, or withhold consent from, loan purchase or sale recommendations made by the Loan Manager, as well as (2) the nearly full ramping and funding of OFS Capital WM’s loan portfolio as of March 2012, OFS Capital had (and continues to have) the right to consent to, or withhold consent from, purchase or sale recommendations made by the Loan Manager with respect to a very high percentage of loans in the OFS Capital WM loan portfolio. Therefore, effective March 30, 2012, OFS Capital possessed (and continues to possess) the power to direct the activities of OFS Capital WM that most significantly impact OFS Capital WM’s economic performance. This resulted in OFS Capital’s succeeding to the controlling financial interest in OFS Capital WM, OFS Capital WM’s discontinuation as a VIE, and OFS Capital’s consolidation of OFS Capital WM, effective March 30, 2012.

The following pro forma presentation assumes OFS Capital’s consolidation of OFS Capital WM took place on January 1, 2012.

OFS Capital Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

(Amounts in thousands, except share and per share data)

Note 3. OFS Capital WM (Continued)

	Nine Months Ended September 30, 2012 (unaudited)

				Pro Forma
	Historical			Adjustments			Pro Forma

Investment income
Interest income from non-affiliate investments	$	9,091		$	4,269	(1)	$	13,360
Dividend and fee income		106			-			106

Total investment income		9,197			4,269			13,466

Expenses
Interest expense		2,956			1,730	(1)		4,686
Amortization of deferred financing closing costs		287			143	(1)		430
Management fees		1,555			267	(1)		1,822
Management fees - other related parties		627			-			627
Professional fees		489			(2	)(1)		487
General and administrative expenses		493			34	(1)		527

Total expenses		6,407			2,172			8,579

Net investment income		2,790			2,097			4,887

Net realized and unrealized gain (loss) on investments
Net realized loss on non-affiliate investments		(1,257	)		-			(1,257	)
Net change in unrealized depreciation on non-affiliate investments		234			548	(1)		782

Net realized and unrealized gain (loss) on investments		(1,023	)		548			(475	)

Other income (loss) prior to becoming a business development company
Income from equity interest in OFS Capital WM		2,645			(2,645	)(1)		-
Income from equity interest in Tamarix LP		378			-			378
Net loss attributable to non-controlling interests		61			-			61
Other income		29			-			29

Total other income (loss) prior to becoming a business development company		3,113			(2,645	)		468

Net increase in net assets before cumulative effect of accounting change		4,880			-			4,880
Cumulative effect of accounting change		570			-			570

Net increase in net assets resulting from operations	$	5,450		$	-		$	5,450

(1)

To eliminate OFS Capital’s income from equity investment in OFS Capital WM and consolidate OFS Capital WM’s statement of operations into OFS Capital’s for the nine months ended September 30, 2012.

OFS Capital Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

(Amounts in thousands, except share and per share data)

Note 4.

Tamarix LP

Tamarix LP is a Delaware limited partnership formed in January 2010, which commenced operations in September 2011. Tamarix LP applied for an SBIC license from the Small Business Administration (“SBA”) in order to become an SBIC regulated fund under the Small Business Investment Company Act of 1958 (the “SBIC Act”). In September and November 2011, OFS Capital entered into loan agreements with Tamarix LP, pursuant to which OFS Capital lent an aggregate of $16,750 to Tamarix LP. Tamarix LP utilized these funds to originate loans with an aggregate face value of $14,750 and acquire equity interests in its borrowers for $2,455. OFS Capital’s loans to Tamarix LP were fully secured by pledges of Tamarix LP’s loans and equity interests in its borrowers.

On May 10, 2012, Tamarix LP received the SBIC license. From September 29, 2011 through May 10, 2012, Tamarix LP was deemed to be a VIE of OFS Capital under ASC Topic 810 as the equity interests in Tamarix LP had not been called and, accordingly, it would not be possible for Tamarix LP to finance its activities without additional subordinated financial support. OFS Capital’s debt interest was considered the sole variable interest in Tamarix LP, and OFS Capital was deemed to be the primary beneficiary in Tamarix LP for the period from September 29, 2011 to May 10, 2012. The investment and exit decisions, day-to-day investment activities and underlying assets of Tamarix LP are managed by its general partner, Tamarix Capital G.P. LLC (“Tamarix GP”), which is controlled by three individuals (“Tamarix Individuals”) who were employed by an affiliate of OFS Capital, and each of whom, together with Glenn Pittson, OFS Capital’s Chief Executive Officer, were approved by the SBA to manage Tamarix LP. For accounting purposes, however, as secured lender to Tamarix LP, as well as employer (through affiliated entity) of the three individuals, OFS Capital ultimately was deemed under the applicable accounting literature to have the power to direct the activities of Tamarix LP that most significantly impacted Tamarix LP’s economic performance. Further, OFS Capital had the obligation as a secured lender to absorb losses of Tamarix LP that could potentially be significant to Tamarix LP.

Since, upon its licensure as an SBIC fund on May 10, 2012, (1) Tamarix LP had (and continues to have) sufficient equity at risk to finance its future activities without additional subordinated financial support, and (2) there continued to be a controlling financial interest holder in Tamarix LP, effective May 10, 2012, Tamarix LP was no longer a VIE but was instead a limited partnership guided under ASC Topic 810. Subsequent to May 10, 2012, OFS Capital was deemed under the applicable accounting literature to continue to hold the controlling financial interest in Tamarix LP since OFS Capital continued to have the power to direct the activities of Tamarix LP that most significantly impact Tamarix LP’s economic performance, and the obligation to absorb losses that could potentially be significant to Tamarix LP. In addition, as the then 68.4% limited partner in Tamarix LP, OFS Capital also possessed the right to receive benefits from Tamarix LP that could potentially be significant to Tamarix LP. Therefore, subsequent to May 10, 2012, OFS Capital continued to consolidate the financial statements of Tamarix LP into its own.

In June 2012, Tamarix LP received a $30,110 SBA leverage commitment, which is issuable by the SBA in the form of debenture securities and which terminates in September 2016. The SBA may limit the amount that may be drawn each year under this commitment, and each issuance of leverage is conditioned on Tamarix LP’s full compliance, as determined by the SBA, with the terms and conditions set forth under the SBIC Act. On July 27, 2012, Tamarix LP made a $14,000 leverage draw. During the nine months ended September 30, 2013, Tamarix LP made a total of $7,000 in additional leverage draws.

The objective of Tamarix LP is to generate attractive returns for investors by making investments in United States-based, lower-middle-market companies. These investments typically will be comprised of debt-related securities with warrant coverage. The term of Tamarix LP runs through the later of March 2022 or two years after all of Tamarix LP’s Outstanding Leverage (as defined in the limited partnership agreement of Tamarix LP) has matured. Pursuant to the limited partnership agreement of Tamarix LP and the SBIC Act, a limited partner may not sell, transfer, assign, pledge, subdivide for resale or otherwise dispose of all or any part of its interest in Tamarix LP without the prior written consent of Tamarix GP, the granting or denying of which consent will be in Tamarix GP’s sole and absolute discretion. In addition, a limited partner may not transfer any interest of ten percent or more in the capital of Tamarix LP without the prior approval of the SBA.

Deconsolidation of Tamarix LP

On July 27, 2012, utilizing the $14,000 in leverage draw from the SBA, Tamarix LP repaid its loans due to OFS Capital, including accrued interest, in the total amount of approximately $16,577. Also effective July 27, 2012, Tamarix Individuals resigned as employees from the affiliated entity of OFS Capital.

OFS Capital Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

(Amounts in thousands, except share and per share data)

Note 4.

Tamarix LP (Continued)

Due to the resignation of Tamarix Individuals, effective July 27, 2012, OFS Capital was no longer deemed to have the power to direct the activities of Tamarix LP that most significantly impact Tamarix LP’s economic performance. Effective July 27, 2012, Tamarix GP, as the general partner of Tamarix LP controlled by Tamarix Individuals, obtained the power from OFS Capital to direct the activities of Tamarix LP that most significantly impact Tamarix LP’s economic performance. In addition, because of Tamarix LP’s payoff of its loans due to OFS Capital, OFS Capital no longer had the obligation to absorb losses from Tamarix LP that could be potentially significant to Tamarix LP as it had prior to July 27, 2012 as a secured lender to Tamarix LP. As a result, effective July 27, 2012, OFS Capital was no longer deemed to hold the controlling interest in Tamarix LP.

Since OFS Capital no longer held the controlling interest in Tamarix LP, effective July 27, 2012, OFS Capital deconsolidated Tamarix LP’s financial statements from its own and adopted the equity method of accounting to record its equity investment in Tamarix LP. Accordingly, the Company’s September 30, 2013 and December 31, 2012 consolidated balance sheets no longer included the accounts of Tamarix LP, and the Company’s consolidated statement of operations for the nine months ended September 30, 2012 reflects the statements of operations from Tamarix LP only through July 27, 2012. Commencing November 8, 2012, as a result of the Company’s election to become a BDC, it accounts for its equity investment in Tamarix LP at fair value.

On July 29, 2013, OFS Capital announced that it had reached an agreement to acquire all of the limited partnership interests in Tamarix LP (“Tamarix LP Acquisition”) that it did not already own and, in conjunction therewith, had submitted documentation to the SBA in connection with its plan to convert Tamarix LP into a wholly-owned subsidiary of OFS Capital. OFS Capital also intends to acquire all of the remaining membership interests in Tamarix GP (“Tamarix GP Acquisition”). The completion of Tamarix LP Acquisition and Tamarix GP Acquisition is still subject to the SBA approval. If OFS Capital obtains the necessary approvals from the SBA, it will increase its capital commitment to Tamarix LP, both directly and through Tamarix GP, to $75 million. Depending upon the details of the final approvals from the SBA, if such approvals are obtained, the portion of the capital commitment that OFS Capital will need to fund at the closing of the drop-down of Tamarix LP is expected to range from $40 million to $50 million.

The following pro forma presentation assumes OFS Capital’s deconsolidation of Tamarix LP took place on January 1, 2012.

OFS Capital Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

(Amounts in thousands, except share and per share data)

Note 4.

Tamarix LP (Continued)

	Nine Months Ended September 30, 2012 (unaudited)

				Pro Forma
	Historical			Adjustments			Pro Forma

Investment income
Interest income from non-affiliate investments	$	9,091		$	(322	)(1)	$	8,769
Dividend and fee income		106			(106	)(1)		-

Total investment income		9,197			(428	)		8,769

Expenses
Interest expense		2,956			(3	)(1)		2,953
Amortization of deferred financing closing costs		287			-			287
Management fees		1,555			-			1,555
Management fees - other related parties		627			(627	)(1)
Professional fees		489			(45	)(1)		444
General and administrative expenses		493			(173	)(1)		320

Total expenses		6,407			(848	)		5,559

Net investment income		2,790			420			3,210

Net realized and unrealized gain (loss) on investments
Net realized loss on non-affiliate investments		(1,257	)		-			(1,257	)
Net change in unrealized depreciation on non-affiliate investments		234			273	(1)		507

Net realized and unrealized gain (loss) on investments		(1,023	)		273			(750	)

Other income (loss) prior to becoming a business development company
Income from equity interest in OFS Capital WM		2,645			-			2,645
Income from equity interest in Tamarix LP		378			(62	)(1)		316
Net loss attributable to non-controlling interests		61			(61	)(1)		-
Other income		29			-			29

Total other income (loss) prior to becoming a business development company		3,113			(123	)		2,990

Net increase in net assets before cumulative effect of accounting change		4,880			570			5,450
Cumulative effect of accounting change		570			(570	)(1)		-

Net increase in net assets resulting from operations	$	5,450		$	-		$	5,450

(1)

To deconsolidate the statement of operations of Tamarix LP for the period January 1, 2012 through July 27, 2012 from OFS Capital’s consolidated statements of operations for the nine months ended September 30, 2012

OFS Capital Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

(Amounts in thousands, except share and per share data)

Note 5.

Related Party Transactions

Investment Advisory and Management Agreement: On November 7, 2012, OFS Capital entered into an Investment Advisory and Management Agreement (“Advisory Agreement”) with OFS Capital Management, LLC, the Company’s Investment Advisor, under which the Investment Advisor manages the day-to-day operations of, and provides investment advisory services to, OFS Capital. Under the terms of the Advisory Agreement and subject to the overall supervision of our Board, the Investment Advisor is responsible for sourcing potential investments, conducting research and diligence on potential investments and equity sponsors, analyzing investment opportunities, structuring investments and monitoring investments and portfolio companies on an ongoing basis. The Investment Advisor is a subsidiary of OFSAM and a registered investment advisor under the Investment Advisers Act of 1940, as amended.

The Investment Advisor’s services under the Advisory Agreement are not exclusive to the Company and the Investment Advisor is free to furnish similar services to other entities so long as its services to the Company are not impaired. The Investment Advisor receives fees for providing services, consisting of two components—a base management fee and an incentive fee. From the completion of the Company’s IPO through October 31, 2013, the base management fee was calculated at an annual rate of 0.875% based on the average value of the Company’s total assets (other than cash and cash equivalents but including assets purchased with borrowed amounts and including assets owned by any consolidated entity) at the end of the two most recently completed calendar quarters. Beginning on November 1, 2013, the base management fee is calculated at an annual rate of 1.75% based on the average value of the Company’s total assets (other than cash and cash equivalents but including assets purchased with borrowed amounts and including assets owned by any consolidated entity) at the end of the two most recently completed calendar quarters. The base management fee is payable quarterly in arrears. The base management fee expense was $497 and $1,516 for the three and nine months ended September 30, 2013, respectively.

The incentive fee has two parts. The first part is calculated and payable quarterly in arrears based on the Company’s pre-incentive fee net investment income for the immediately preceding calendar quarter. For this purpose, pre-incentive fee net investment income means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees received from portfolio companies) accrued during the calendar quarter, minus operating expenses for the quarter (including the base management fee, expenses payable under the Administration Agreement (as defined below), and any interest expense and any dividends paid on any issued and outstanding preferred stock, but excluding the incentive fee).

Pre-incentive fee net investment income includes, in the case of investments with a deferred interest feature (such as original issue discount, debt instruments with payment-in-kind interest and zero coupon securities), accrued income that the Company has not yet received in cash. Pre-incentive fee net investment income is expressed as a rate of return on the value of the Company’s net assets (defined as total assets less indebtedness and before taking into account any incentive fees payable during the period) at the end of the immediately preceding calendar quarter. The incentive fee with respect to the pre-incentive fee net income is 20.00% of the amount, if any, by which the pre-incentive fee net investment income for the immediately preceding calendar quarter exceeds a 2.00% (which is 8.00% annualized) hurdle rate and a “catch-up” provision measured as of the end of each calendar quarter. Under this provision, in any calendar quarter, the Investment Advisor receives no incentive fee until the net investment income equals the hurdle rate of 2.00%, but then receives, as a “catch-up,” 100.00% of the pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than 2.5%. The effect of this provision is that, if pre-incentive fee net investment income exceeds 2.5% in any calendar quarter, the Investment Advisor will receive 20.00% of the pre-incentive fee net investment income.

Pre-incentive fee net investment income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. Because of the structure of the incentive fee, it is possible that the Company may pay an incentive fee in a quarter in which the Company incurs a loss. For example, if the Company receives pre-incentive fee net investment income in excess of the quarterly minimum hurdle rate, the Company will pay the applicable incentive fee even if the Company has incurred a loss in that quarter due to realized and unrealized capital losses. The Company’s net investment income used to calculate this part of the incentive fee is also included in the amount of the Company’s gross assets used to calculate the base management fee. These calculations are appropriately prorated for any period of less than three months and adjusted for any share issuances or repurchases during the current quarter.

OFS Capital Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

(Amounts in thousands, except share and per share data)

Note 5.

Related Party Transactions (Continued)

The second part of the incentive fee (the “Capital Gain Fee”) is determined and payable in arrears as of the end of each calendar year (or upon termination of the Advisory Agreement, as of the termination date), commencing on December 31, 2012, and equals 20% of the Company’s aggregate realized capital gains, if any, on a cumulative basis from the date of the election to be a BDC through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation through the end of such year, less all previous amounts paid in respect of the capital gain incentive fee; provided that the incentive fee determined as of December 31, 2012 was calculated for a period of shorter than twelve calendar months to take into account any realized capital gains computed net of all realized capital losses and unrealized capital depreciation for the period beginning on the date of the Company’s election to be a BDC and ending December 31, 2012.

The Company accrues the Capital Gain Fee if, on a cumulative basis, the sum of net realized capital gains and (losses) plus net unrealized appreciation and (depreciation) is positive.

The Company did not incur any incentive fee expense for the three and nine months ended September 30, 2013.

Prior to the Company’s election to become a BDC, the Investment Advisor served as its advisor effective September 28, 2010, under an Investment Advisory Agreement pursuant to which OFS Capital paid an annual base management fee to the Investment Advisor to compensate for its investment advisory services. The base management fee was calculated initially at 2% per annum of the Company’s average total assets (excluding cash) at the end of the two most recently completed calendar quarters and was amended on March 30, 2012, pursuant to which OFS Capital paid a base management fee of 2% per annum on its average total assets excluding cash and the assets held by OFS Capital WM. For the assets held by OFS Capital WM at the subsidiary level, OFS Capital paid a base management fee of 0.5% per annum on the average total assets (excluding cash) of OFS Capital WM. For the three and nine months ended September 30, 2012, the Company incurred management fee expense to its investment advisor of $331 and $1,041, respectively.

Administration Agreement: On November 7, 2012, OFS Capital entered into an administration agreement (“Administration Agreement”) with OFS Capital Services, LLC (“OFS Capital Services” or the “Administrator”), a wholly-owned subsidiary of OFSAM. Pursuant to the Administration Agreement, the Administrator furnishes the Company with office facilities and equipment, necessary software licenses and subscriptions and clerical, bookkeeping and record keeping services at such facilities. Under the Administration Agreement, the Administrator performs, or oversees, the performance of, the Company’s required administrative services, which include being responsible for the financial records that the Company is required to maintain and preparing reports to its stockholders and all other reports and materials required to be filed with the SEC or any other regulatory authority. In addition, the Administrator assists the Company in determining and publishing its net asset value, oversees the preparation and filing of its tax returns and the printing and dissemination of reports to its stockholders, and generally oversees the payment of the Company’s expenses and the performance of administrative and professional services rendered to the Company by others. Under the Administration Agreement, the Administrator also provides managerial assistance on the Company’s behalf to those portfolio companies that have accepted the Company’s offer to provide such assistance. Payment under the Administration Agreement is equal to an amount based upon the Company’s allocable portion of the Administrator’s overhead in performing its obligations under the Administration Agreement, including rent and the Company’s allocable portion of the cost of its officers, including its chief executive officer, chief financial officer, chief compliance officer, chief accounting officer, and their respective staffs. For the three and nine months ended September 30, 2013, the Company incurred an administration fee expense of $200 and $657, respectively.

Other Related Party Transactions:

Distributions from OFS Capital WM

In January 2012, OFS Capital received a cash distribution from OFS Capital WM in the amount of $1,225.

Distribution due from Tamarix LP

At September 30, 2013, the Company had a $91 tax distribution receivable due from Tamarix LP included in prepaid expenses and other assets on the consolidated balance sheet.

Investment in and Due from Tamarix GP

OFS Capital holds a 23.35% membership interest in Tamarix GP, which has a 1% limited partnership interest in Tamarix LP. The membership interest in Tamarix GP was carried at $17 and zero ($0) as of September 30, 2013 and December 31, 2012, respectively.

OFS Capital Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

(Amounts in thousands, except share and per share data)

Note 5.

Related Party Transactions (Continued)

Through December 31, 2012, OFS Capital had funded $20 for its investment in Tamarix GP. During the nine months ended September 30, 2013, OFS Capital funded an additional $17 in Tamarix GP. In April 2012, OFS Capital received a tax distribution from Tamarix GP in the amount of $52.

During 2012, OFS Capital made advances totaling $69 to Tamarix GP for certain operating expenses paid by OFS Capital for the benefit of Tamarix GP, which amount was outstanding at September 30, 2013.

Investment in Tamarix Associates, LLC

OFS Capital holds a 23.33% fee interest in Tamarix Associates, LLC (“Tamarix Manager”), the investment manager for Tamarix LP, which is controlled by the three Tamarix Individuals who, together with Glenn Pittson, OFS Capital’s Chief Executive Officer, own the remaining fee interests. As of September 30, 2013 and December 31, 2012, OFS Capital was not obligated to make any capital contribution to Tamarix Manager, and its equity investment in Tamarix Manager was carried at zero ($0) at September 30, 2013.

Management Fee Payable – Related Party

Tamarix LP is charged a management fee by Tamarix Manager. During the investment period as defined under the SBIC Act, Tamarix LP incurs a management fee to Tamarix Manager at a per annum rate of 2.0% of the sum of Tamarix LP’s 1) unreduced regulatory capital as defined under the SBIC Act plus 2) the assumed leverage from the SBA equal to two times Tamarix LP’s unreduced regulatory capital. Thereafter, Tamarix LP will need to pay Tamarix Manager an annual management fee equal to 2.0% of Tamarix LP’s cost of loans and investments in active small businesses. Prior to the deconsolidation of Tamarix LP, for the period January 1, 2012 through July 27, 2012, OFS Capital recorded management fee expense in the amount of $627 on its consolidated statement of operations.

OFS Capital Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

(Amounts in thousands, except share and per share data)

Note 6.

Investments

At September 30, 2013, investments consisted of the following:

	Principal		Cost		Fair Value
Senior secured debt	$	213,904	$	211,661	$	207,975
Equity investment in Tamarix LP		N/A		10,115		11,322
Total	$	213,904	$	221,776	$	219,297

At September 30, 2013, the industry compositions of the Company’s portfolio were as follows:

	Cost				Fair Value
Aerospace & Defense	$	6,913	3.1	%	$	6,933	3.2	%
Automotive		7,254	3.3			7,217	3.3
Banking, Finance, Insurance & Real Estate		44,110	19.9			45,128	20.6
Beverage, Food & Tobacco		7,095	3.2			6,947	3.2
Capital Equipment		8,011	3.6			7,990	3.7
Chemicals, Plastics & Rubber		19,818	8.9			19,817	9.0
Construction & Building		6,508	2.9			6,525	3.0
Consumer goods: Non-durable		7,833	3.5			7,520	3.4
Containers, Packaging & Glass		4,296	1.9			4,262	1.9
Energy: Oil & Gas		11,541	5.2			11,511	5.2
Environmental Industries		7,971	3.6			7,858	3.6
Healthcare & Pharmaceuticals		46,778	21.1			44,152	20.1
High Tech Industries		5,082	2.3			4,942	2.3
Media: Advertising, Printing & Publishing		10,299	4.7			10,387	4.7
Media: Broadcasting & Subscription		4,305	2.0			4,394	2.0
Retail		8,518	3.9			8,521	3.9
Services: Business		7,632	3.4			7,552	3.4
Telecommunications		7,812	3.5			7,641	3.5
	$	221,776	100.0	%	$	219,297	100.0	%

OFS Capital Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

(Amounts in thousands, except share and per share data)

Note 6.

Investments (Continued)

At December 31, 2012, investments consisted of the following:

	Principal		Cost		Fair Value
Senior secured debt	$	234,635	$	231,781	$	227,542
Equity investment in Tamarix LP		N/A		5,049		4,657
Total	$	234,635	$	236,830	$	232,199

At December 31, 2012, the industry compositions of the Company’s portfolio were as follows:

	Cost				Fair Value
Aerospace & Defense	$	7,294	3.1	%	$	7,177	3.1	%
Automotive		12,485	5.3			11,618	5.0
Banking, Finance, Insurance & Real Estate		49,652	21.0			48,727	21.0
Beverage, Food and Tobacco		7,166	3.0			7,072	3.0
Business Equipment & Services		7,926	3.3			7,907	3.4
Chemical, Plastics & Rubber		10,179	4.3			10,306	4.4
Construction & Building		11,619	4.9			11,311	4.9
Consumer Goods: Non-durable		8,620	3.6			8,186	3.5
Containers, Packaging & Glass		4,477	1.9			4,379	1.9
Energy: Oil & Gas		12,023	5.1			12,081	5.2
Environmental Industries		8,709	3.7			8,584	3.7
Healthcare & Pharmaceuticals		46,530	19.6			44,909	19.3
High Tech Industries		5,265	2.2			5,289	2.3
Consumer Goods: Durable		3,564	1.5			3,544	1.5
Media: Advertising, Printing & Publishing		7,604	3.2			7,583	3.3
Media: Broadcasting & Subscription		4,549	1.9			4,549	2.0
Retail		9,464	4.0			9,436	4.1
Services: Business		9,414	4.0			9,184	4.0
Telecommunications		10,290	4.4			10,357	4.4
	$	236,830	100.0	%	$	232,199	100.0	%

OFS Capital Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

(Amounts in thousands, except share and per share data)

Note 7.

Fair Value of Financial Instruments

The Company follows ASC Topic 820 for measuring fair value. Prior to the Company’s election to become a BDC, the Company also followed the guidance in ASC Topic 820 in disclosing the fair value reported for all financial instruments that were either impaired or available for sale securities, using the definitions provided in Accounting Standards Codification Topic 320, “Investments – Debt and Equity Securities” (“ASC Topic 320”). Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date and sets out a fair value hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). Inputs are broadly defined under ASC Topic 820 as assumptions market participants would use in pricing an asset or liability. The three levels of the fair value hierarchy under ASC Topic 820 are described below:

Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

Level 2: Inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly; and fair value is determined through the use of models or other valuation methodologies.

Level 3: Inputs are unobservable for the asset or liability and include situations where there is little, if any, market activity for the asset or liability. The inputs into the determination of fair value are based upon the best information under the circumstances and may require significant management judgment or estimation.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the investment.

The Company assesses the levels of the investments at each measurement date, and transfers between levels are recognized on the subsequent measurement date closest in time to the actual date of the event or change in circumstances that caused the transfer. There were no transfers among Level 1, 2 and 3 for the three and nine months ended September 30, 2013 and 2012. The following sections describe the valuation techniques used by the Company to measure different financial instruments at fair value and include the levels within the fair value hierarchy in which the financial instruments are categorized.

Investments for which prices are not observable are generally private investments in the equity and debt securities of operating companies. The primary analytical method used to estimate the fair value of Level 3 investments is the discounted cash flow method (although in certain instances a liquidation analysis, option theoretical, or other methodology may be most appropriate). The discounted cash flow approach to determine fair value (or a range of fair values) involves applying an appropriate discount rate(s) to the estimated future cash flows using various relevant factors depending on investment type, including assumed growth rate (in cash flows) and capitalization rates/multiples (for determining terminal values of underlying portfolio companies). The valuation based on the inputs determined to be the most reasonable and probable is used as the fair value of the investment. The determination of fair value using these methodologies may take into consideration a range of factors including, but not limited to, the price at which the investment was acquired, the nature of the investment, local market conditions, trading values on public exchanges for comparable securities, current and projected operating performance, and financing transactions subsequent to the acquisition of the investment. Application of these valuation methodologies involves a significant degree of judgment by management.

The fair value of equity securities, including warrants, in portfolio companies may also consider the market approach—that is, through analyzing, and applying to the underlying portfolio companies, market valuation multiples of publicly-traded firms engaged in businesses similar to those of the portfolio companies. The market approach to determining the fair value of a portfolio company’s equity security (or securities) will typically involve: (1) applying to the portfolio company’s trailing twelve months (or current year projected) EBITDA a low to high range of enterprise value to EBITDA multiples that are derived from an analysis of publicly-traded comparable companies, in order to arrive at a range of enterprise values for the portfolio company; (2) subtracting from the range of calculated enterprise values the outstanding balances of any debt or equity securities that would be senior in right of payment to the equity securities held by the Company; and (3) multiplying the range of equity values derived therefrom by the Company’s ownership share of such equity tranche in order to arrive at a range of fair values for the Company’s equity security (or securities). Application of these valuation methodologies involves a significant degree of judgment by management.

OFS Capital Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

(Amounts in thousands, except share and per share data)

Note 7.

Fair Value of Financial Instruments (Continued)

Equity in a portfolio company that invests in loans will typically be valued by arriving at a fair value of such vehicle’s loan assets (plus, when appropriate, the carrying value of certain other assets), and deducting the book value or fair value (as appropriate) of such vehicle’s liabilities to arrive at a fair value for the equity. When appropriate, in order to recognize value that would be created by growth opportunities of such portfolio company, equity in a portfolio company may also be valued by taking into consideration the magnitude, timing, and effective life of its expected future investments in loans.

Due to the inherent uncertainty of determining the fair value of Level 3 investments that do not have a readily available market value, the fair value of the investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values that may ultimately be received or settled. Further, such investments are generally subject to legal and other restrictions or otherwise are less liquid than publicly traded instruments. If the Company were required to liquidate a portfolio investment in a forced or liquidation sale, the Company might realize significantly less than the value at which such investment had previously been recorded. With respect to Level 3 investments, where sufficient market quotations are not readily available or for which no or an insufficient number of indicative prices from pricing services or brokers or dealers have been received, the Company undertakes, on a quarterly basis, a valuation process as described below:

•

For each debt investment, a basic credit rating review process is completed. The risk rating on every credit facility is reviewed and either reaffirmed or revised by the Investment Advisor’s investment committee.

•

Each portfolio company or investment is valued by an investment professional.

•

Preliminary valuation conclusions are then documented and discussed with individual members of the investment committee.

•

The preliminary valuations are then submitted to the investment committee for ratification.

•

Third party valuation firm(s) will be engaged to provide valuation services as requested, by reviewing the investment committee’s preliminary valuations. The investment committee’s preliminary fair value conclusions on each of the Company’s assets for which sufficient market quotations are not readily available will be reviewed and assessed by a third-party valuation firm at least once in every 12-month period, and more often as determined by the Company’s Board or required by the Company’s valuation policy. Such valuation assessment may be in the form of positive assurance, range of values or other valuation method based on the discretion of the Company’s Board.

•

The Company’s Board will discuss valuations and determine the fair value of each investment in the portfolio in good faith based on the input of OFS Capital Management, LLC and, where appropriate, the respective independent valuation firms.

The Company’s investments are subject to market risk. Market risk is the potential for changes in the value of investments due to market changes. Market risk is directly impacted by the volatility and liquidity in the markets in which the investments are traded. The Company manages its exposure to market risk related to its investments through monitoring the financial condition of its investments, as well as the volatility and liquidity trends of the markets in which it trades.

The following tables present fair value measurements of the Company’s investments and indicate the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value:

OFS Capital Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

(Amounts in thousands, except share and per share data)

Note 7.

Fair Value of Financial Instruments (Continued)

	September 30, 2013
	Fair Value Measurements Using
Description	(Level I)		(Level II)		(Level III)		Total

Assets:
Debt investments	$	-	$	-	$	207,975	$	207,975
Equity investments		-		-		11,322		11,322
Money market funds*		6,733		-		-		6,733

Total	$	6,733	$	-	$	219,297	$	226,030

* included in cash and cash equivalents and restricted cash and cash equivalents on the consolidated balance sheet.

The Company had one category of debt investments at September 30 2013, consisting of senior loans to 55 portfolio companies. The debt investments were measured at fair value via application of the discounted cash flow method, based on discount rates (derived primarily from unobservable credit quality and unobservable market interest rate inputs) ranging from 6.85% to 25.00%, with a weighted average rate of 8.29% and unobservable EBITDA multiple inputs ranging from 4.00 to 9.78, with a weighted average multiple of 6.74. Changes in credit quality (which would impact the discount rate), as well as changes in EBITDA multiples, could have a significant impact on fair values, with the fair value of a particular debt investment susceptible to change in inverse relation to changes in the discount rate.

The Company determined the fair value of its equity investment in Tamarix LP at September 30, 2013 by determining the total of: (1) the fair value of the debt and equity securities held by Tamarix LP as of September 30, 2013 in the aggregate amount of $30,824; plus (2) the carrying value of Tamarix LP’s cash, receivables, and other assets in the total amount of $7,901; less (3) the carrying value of Tamarix LP’s liabilities in the total amount of $21,255; times (4) the Company’s percentage share of Tamarix LP’s paid in capital as of September 30, 2013.

At September 30, 2013, Tamarix LP’s debt investments in five portfolio companies were measured at fair value via application of the discounted cash flow method, based on discount rates (derived primarily from unobservable credit quality and unobservable market interest rate inputs) ranging from 13.60% to 15.90%, with a weighted average rate of 14.98%, and unobservable EBITDA multiple inputs ranging from 3.72 to 6.89, with a weighted average of 4.95. Changes in credit quality (which would impact the discount rate), as well as changes in EBITDA multiples, could have a significant impact on fair values, with the fair value of a particular debt investment susceptible to change in inverse relation to changes in the discount rate.

At September 30, 2013, Tamarix LP’s equity investments in five portfolio companies were measured at fair value via: (1) application of the discounted cash flow method, based on discount rates ranging from 20% to 40% and unobservable EBITDA multiple inputs ranging from 3.72 to 6.89, as well as (2) application of the market approach, utilizing unobservable EBITDA multiple inputs of 3.31 to 9.51. Changes in EBITDA multiples, as well as changes in the discount rate, could have a significant impact on fair values, with the fair value of an equity investment susceptible to change in tandem with changes in EBITDA multiples, and in inverse relation to changes in the discount rate.

OFS Capital Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

(Amounts in thousands, except share and per share data)

Note 7.

Fair Value of Financial Instruments (Continued)

	December 31, 2012
	Fair Value Measurements Using
Description	(Level I)		(Level II)		(Level III)		Total

Assets:
Debt investments	$	-	$	-	$	227,542	$	227,542
Equity investments		-		-		4,657		4,657
Money market funds *		6,103		-		-		6,103
								-
Total	$	6,103	$	-	$	232,199	$	238,302

* included in cash and cash equivalents and restricted cash and cash equivalents on the consolidated balance sheet.

The Company had one category of debt investments at December 31, 2012, consisting of senior loans to 58 portfolio companies. The debt investments were measured at fair value via application of the discounted cash flow method, based on discount rates (derived primarily from unobservable credit quality and unobservable market interest rate inputs) ranging from 7.44% to 15.80%, with a weighted average rate of 8.29% and unobservable EBITDA multiple inputs ranging from 3.75 to 9.03, with a weighted average multiple of 6.13. Changes in credit quality (which would impact the discount rate), as well as changes in EBITDA multiples, could have a significant impact on fair values, with the fair value of a particular debt investment susceptible to change in inverse relation to changes in the discount rate.

The Company determined the fair value of its equity investment in Tamarix LP at December 31, 2012 by determining the total of: (1) the fair value of the debt and equity securities held by Tamarix LP as of December 31, 2012 in the aggregate amount of $20,903; plus (2) the carrying value of Tamarix LP’s cash and receivables in the total amount of $944; less (3) the carrying value of Tamarix LP’s liabilities in the total amount of $14,383; times (4) the Company’s percentage share of Tamarix LP’s paid in capital as of December 31, 2012.

At December 31, 2012, Tamarix LP’s debt investments in three portfolio companies were measured at fair value via application of the discounted cash flow method, based on discount rates (derived primarily from unobservable credit quality and unobservable market interest rate inputs) ranging from 13.02% to 15.0%, with a weighted average rate of 14.64%, and unobservable EBITDA multiple inputs ranging from 4.08 to 6.48, with a weighted average of 4.81. Changes in credit quality (which would impact the discount rate), as well as changes in EBITDA multiples, could have a significant impact on fair values, with the fair value of a particular debt investment susceptible to change in inverse relation to changes in the discount rate.

At December 31, 2012, Tamarix LP’s equity investments in three portfolio companies were measured at fair value via: (1) application of the discounted cash flow method, based on discount rates ranging from 20.0%-30.0% and unobservable EBITDA multiple inputs ranging from 4.08 to 6.48, as well as (2) application of the market approach, utilizing unobservable EBITDA multiple inputs of 3.23 to 8.44. Changes in EBITDA multiples, as well as changes in the discount rate, could have a significant impact on fair values, with the fair value of an equity investment susceptible to change in tandem with changes in EBITDA multiples, and in inverse relation to changes in the discount rate.

OFS Capital Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

(Amounts in thousands, except share and per share data)

Note 7.

Fair Value of Financial Instruments (Continued)

The following table presents changes in investments measured at fair value using Level 3 inputs for the nine months ended September 30, 2013, and 2012.

	For the Nine Months Ended September 30,
	2013									2012
	Debt			Equity			Total			Debt			Equity			Total

Level 3 assets, beginning of period	$	227,542		$	4,657		$	232,199		$	-		$	-		$	-

Net change in unrealized depreciation on non-affiliate investments		554			-			554			460			-			460
Net change in unrealized appreciation on affiliate investments		-			1,599			1,599			-			(226	)		(226	)
Net realized loss on investment - related party		-			-			-			(1,257	)		-			(1,257	)
Consolidation of investments held by OFS Capital WM		-			-			-			197,765			-			197,765
Purchase of portfolio investments		30,591			-			30,591			30,839			-			30,839
Additional equity investment in Tamarix LP		-			5,157			5,157			2,999			-			2,999
Accrued PIK		-			-			-			99			-			99
Portfolio investments of Tamarix LP converted from cost to fair value accounting		-			-			-			14,382			2,596			16,978
Proceeds from principal payments on portfolio investments held by OFS Capital WM		(46,976	)		-			(46,976	)		(17,476	)		-			(17,476	)
Proceeds from principal payments on portfolio investments held by Tamarix LP		-			-			-			(315	)		-			(315	)
Sale of portfolio investments to related party		-			-			-			(3,722	)		-			(3,722	)
Sale of portfolio investments to others		(4,708	)		-			(4,708	)		-			-			-
Portfolio investment received in connection with debt acquisition and restructuring by Tamarix LP		-			-			-			-			539			539
Deconsolidation of investments in Tamarix LP		-			-			-			(17,200	)		(2,909	)		(20,109	)
Distribution receivable from Tamarix LP		-			(91	)		(91	)		-			-			-
Amortization of discounts and premium		972			-			972			622			-			622
Level 3 assets, end of period
	$	207,975		$	11,322		$	219,297		$	207,196		$	-		$	207,196

The net change in unrealized depreciation for the nine months ended September 30, 2013 and 2012 reported within the net change in unrealized depreciation on non-affiliate investments in the Company’s consolidated statements of operations attributable to the Company’s level 3 assets held at September 30, 2013 and 2012 was $182 and $(906), respectively. The net change in unrealized appreciation for the nine months ended September 30, 2013 reported within the net change in unrealized appreciation on affiliate investments in the Company’s consolidated statements of operations attributable to the Company’s level 3 assets held at September 30, 2013 was $1,599.

The Company discloses fair value information about financial instruments, whether or not recognized in the balance sheet, for which it is practicable to estimate that value. Certain financial instruments are excluded from the disclosure requirements. Accordingly, the aggregate fair value amounts presented do not represent the underlying value of the Company.

The information presented should not be interpreted as an estimate of the fair value of the entire company since a fair value calculation is only required for a limited portion of the Company’s assets and liabilities. Due to the wide range of valuation techniques and the degree of subjectivity used in making the estimates, comparisons between the Company’s disclosures and those of other companies may not be meaningful.

As of September 30, 2013 and December 31, 2012, the carrying value of the Company’s financial instruments approximated their estimated fair value.

OFS Capital Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

(Amounts in thousands, except share and per share data)

Note 8.

Commitments and Contingencies

At September 30, 2013 and December 31, 2012, the Company had a $1,500 unused line of credit granted to a borrower.

On March 27, 2012, we entered into a new subscription agreement (“Subscription Agreement”) with respect to an investment in Tamarix LP, which superseded prior agreements and was contingent upon issuance of the license from the SBA. Under the terms of the Subscription Agreement, our investment in Tamarix LP will not exceed $25,000. On April 2, 2012, OFS Capital funded $1,584 to Tamarix LP. In March and April 2012, Tamarix LP also received an aggregate of $207 and $709, respectively, from other investors. These funds, totaling $2,500, were called by Tamarix LP as requested by the SBA and would be used as initial capital of Tamarix LP once Tamarix LP received the SBIC license. On May 10, 2012, as a result of Tamarix LP’s receipt of the SBIC license, our equity investment in Tamarix LP was no longer contingent and our advance to Tamarix LP in the amount of $1,584 was reclassified as an equity investment in Tamarix LP. In July 2012, we made an additional equity investment of $3,242 in Tamarix LP.

During the nine months ended September 30, 2013, we made additional equity investments in Tamarix LP totaling $5,157. As of September 30, 2013, our committed but uncalled capital investment in Tamarix LP was approximately $15,000.

From time to time, the Company is involved in legal proceedings in the normal course of its business. Although the outcome of such litigation cannot be predicted with any certainty, management is of the opinion, based on the advice of legal counsel, that final disposition of any litigation should not have a material adverse effect on the financial position of the Company.

In the normal course of business, the Company enters into contracts and agreements that contain a variety of representations and warranties that provide general indemnifications. The Company’s maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Company that have not occurred. The Company believes the risk of any material obligation under these indemnifications to be unlikely.

Note 9.

Revolving Line of Credit

On September 28, 2010, OFS Capital WM entered into a $180,000 secured revolving credit facility (as amended from time to time, the “OFS Capital WM Credit Facility”) with Wells Fargo and Madison Capital Funding, LLC (“Madison Capital”, an affiliated entity of the Loan Manager), with the Class A lenders (initially Wells Fargo) providing up to $135,000 in Class A loans (“Class A Facility”) and the Class B lenders (initially Madison Capital) providing up to $45,000 in Class B loans to OFS Capital WM (“Class B Facility”). The OFS Capital WM Credit Facility is secured by the eligible loans transferred to OFS Capital WM by OFS Capital on September 28, 2010 and any eligible loan assets subsequently acquired by OFS Capital WM. The loan facilities with Wells Fargo and Madison Capital had five- and six-year terms, respectively, and both facilities provided a one-year option for extension upon the approval of the Class A and Class B lenders. The loan facilities had a reinvestment period of two years after the closing date of the OFS Capital WM Credit Facility, which could be extended by one year with the consent of each lender. Outstanding borrowings on the loan facilities were limited to the lesser of (1) $180,000 and (2) the borrowing base as defined by the OFS Capital WM Credit Facility loan documents. OFS Capital WM is obligated to pay interest on outstanding Class A loans and Class B loans (until the termination of the Class B Facility in January 2013) on each quarterly payment date. Prior to September 28, 2012, outstanding Class A loans accrued interest equal to LIBOR plus 3.00% per annum, and outstanding Class B loans accrued interest equal to LIBOR plus 4.00% per annum. OFS Capital WM has the right to repay loans outstanding under the facility in part from time to time, subject to applicable prepayment fee. The unused commitment fee on the Class A Facility is (1) 0.5% per annum of the first $25,000 of the unused facility and (2) 2% per annum of the balance in excess of $25,000. The unused commitment fee on the Class B Facility was 0.5% per annum. In connection with the closing of the OFS Capital WM Credit Facility, OFS Capital WM incurred financing costs of $3,501, which were deferred and amortized over the terms of OFS Capital WM Credit Facility.

Under the OFS Capital WM Credit Facility, the Loan Manager charges both a senior and subordinated management fee to OFS Capital WM for its services, each at 0.25% per annum of the assigned value of the underlying portfolio investments, which value is determined by the Controlling Lender (as defined in the OFS Capital WM loan documents), plus an accrued fee that is deferred until after the end of the investment period of the portfolio investments. For the three and nine months ended September 30, 2013 the Company incurred management fee expense of $247 and $829, respectively, to the Loan Manager. For the three and nine months ended September 30, 2012 the Company incurred management fee expense of $261 and $514, respectively, to the Loan Manager.

On September 28, 2012, the OFS Capital WM Credit Facility was amended. Pursuant to the amendment, (1) the loans with both Wells Fargo and Madison Capital were extended to December 31, 2016, and both loans provided for a one-year option for extension upon the approval of the Class A and Class B lenders; (2) the reinvestment period for both loans was extended to December 31, 2013, which could be further extended by one year with the consent of each lender; (3) the accrued interest rate on outstanding Class A loans was amended to LIBOR plus 2.75% per annum, and (4) the accrued interest rate on outstanding Class B loans was amended to LIBOR plus 6.50%. In connection with the amendment, OFS Capital WM incurred financing costs of $675. The deferred financing costs under the amended OFS Capital WM Credit Facility, together with the original unamortized deferred financing costs of $2,350 at September 28, 2012, are being amortized over the term of the OFS Capital WM Credit Facility. On January 22, 2013, the OFS Capital WM Credit Facility was further amended, pursuant to which the Class B Facility was terminated. As a result, the WM Credit Facility was reduced from $180,000 to $135,000. In connection with the termination of the Class B Facility, OFS Capital WM wrote off unamortized deferred financing costs attributable to the Class B loan in the amount of $299.

OFS Capital Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

(Amounts in thousands, except share and per share data)

Note 10.

Financial Highlights

The financial highlights for the Company are as follows:

	Three Months Ended			Nine Months Ended
	September 30, 2013 (1)			September 30, 2013 (1)

Per share data:
Net asset value at beginning of period	$	14.76		$	14.80
Dividends and distributions		(0.34	)	$	(1.02	)
Net investment income		0.15		$	0.45
Net realized gain on investments		-			-
Net change in unrealized depreciation on non-affiliate investments		(0.16	)		0.06
Net change in unrealized appreciation on affiliate investments		0.05			0.17
Net asset value at end of period	$	14.46		$	14.46

Per share market value, end of period	$	12.66		$	12.66
Total return based on market value		9.2	%(2)		(0.1	)%(2)
Shares outstanding at end of period		9,626,987			9,626,987
Ratios to average net assets:
Expense without incentive fees		7.3	%(3)		7.8	%(3)
Incentive fees		-	(3)		-	(3)
Total expenses		7.3	%(3)		7.8	%(3)
Net investment income without incentive fees		4.0	%(3)		4.1	%(3)
Average net asset value	$	140,605	(4)	$	141,228	(5)

(1)

For historical periods that include financial results prior to November 7, 2012, the Company did not have common shares outstanding or an equivalent and, therefore, earnings per share, dividends and distributions declared per common shares and weighted average shares outstanding information for periods that include financial results prior to November 7, 2012 are not provided.

(2)

Calculation is ending market value less beginning market value, adjusting for dividends and distributions.

(3)

Annualized.

(4)

Based on the average of net asset values at June 30, 2013 and September 30, 2013.

(5)

Based on the average of net asset values at December 31, 2012, March 31, 2013, June 30, 2013 and September 30, 2013.

OFS Capital Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

(Amounts in thousands, except share and per share data)

Note 11.

Dividends and Distributions

The Company records dividends and distributions on the declaration date. Prior to November 7, 2012, the Company did not have common shares outstanding or an equivalent and therefore had no dividends or distributions for the nine months ended September 30, 2012.

The Company determines if a portion of its distributions may be deemed a tax return of capital to its shareholders at the end of each fiscal year. However, if the characteristics of such distribution were determined as of March 31, 2013, June 30, 2013, and September 30, 2013, the Company estimates that approximately $0.18, $0.37 and $0.55 per share, respectively, would have been characterized as a tax return of capital to its shareholders for the three months ended March 31, 2013, six months ended June 30, 2013, and nine months ended September 30, 2013.

The following table summarizes dividends and distributions declarations during the nine months ended September 30, 2013.

			Amount
Date Declared	Record Date	Payment Date	Per Share		Total Amount
March 26, 2013	April 17, 2013	April 30, 2013	$	0.34	$	3,269
June 25, 2013	July 17, 2013	July 31, 2013		0.34		3,272
September 25, 2013	October 17, 2013	October 31, 2013		0.34		3,273
Total declared for the nine months ended September 30, 2013			$	1.02	$	9,814

The Company has adopted a DRIP that provides for reinvestment of any distributions the Company declares in cash on behalf of its stockholders, unless a stockholder elects to receive cash. The following table summarizes dividend reinvestment plan activity for the nine months ended September 30, 2013.

	For the nine months
	ended September 30, 2013
Shares issued		48,296
Average price per share	$	14.18

Note 12.

Earnings per Share

The following table summarizes the calculations for basic and diluted net increase (decrease) in net assets resulting from operations per common share for the three and nine months ended September 30, 2013. Prior to November 7, 2012, the Company did not have common shares outstanding or an equivalent and therefore had no dividends or distributions for the nine months ended September 30, 2012.

	For the three months ended		For the nine months ended
	September 30, 2013		September 30, 2013

Net increase (decrease) in net assets resulting from operations	$	366	$	6,494
Basic and diluted weighted average shares outstanding		9,626,336		9,616,637
Net increase (decrease) in net assets resulting from operations per common share - basic and diluted	$	0.04	$	0.67

Note 13.

Subsequent Events

On October 31, 2013, the Company paid a dividend of $0.34 per share for the 2013 third quarter to shareholders of record at October 17, 2013. In connection with the dividend, the Company made cash payments of $3,240 and issued 2,810 shares of common stock.

In preparing these financial statements, the Company has evaluated subsequent events and transactions for potential recognition and/or disclosure.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This quarterly report on Form 10-Q contains forward-looking statements that involve substantial risks and uncertainties. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about us, our current and prospective portfolio investments, our industry, our beliefs, and our assumptions. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “would,” “should,” “targets,” “projects,” and variations of these words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without limitation:

•

our limited experience operating a business development company, or BDC, or a small business investment company, or SBIC, or qualifying as a regulated investment company, or RIC, under Subchapter M of the Internal Revenue Code of 1986, or the Code;

•

our dependence on key personnel;

•

our ability to maintain or develop referral relationships;

•

the administration of OFS Capital WM, LLC’s, or OFS Capital WM’s, portfolio by an unaffiliated loan manager;

•

management of the day-to-day operations of Tamarix Capital Partners, LP, or Tamarix LP, and its portfolio investments by its manager, which we do not control;

•

our ability to replicate historical results;

•

the ability of OFS Capital Management, LLC, or OFS Advisor, to identify, invest in and monitor companies that meet our investment criteria;

•

actual and potential conflicts of interest with OFS Advisor and other affiliates of Orchard First Source Asset Management, LLC, or OFSAM;

•

constraint on investment due to access to material nonpublic information;

•

restrictions on our ability to enter into transactions with our affiliates;

•

our ability to obtain necessary approvals, including from the U.S. Small Business Administration, or SBA, in connection with our proposed acquisition of the ownership interests in Tamarix LP and Tamarix Capital G.P. LLC, or Tamarix GP, the limited liability company that functions as the general partner of Tamarix LP, that we do not already own;

•

our receipt of exemptive relief from the Securities Exchange Commission, or SEC, to permit us to exclude the debt of Tamarix LP from our asset coverage test;

•

limitations on the amount of SBA-guaranteed debentures that may be issued by an SBIC;

•

Tamarix LP’s ability to comply with SBA regulations and requirements;

•

the use of borrowed money to finance a portion of our investments;

•

competition for investment opportunities;

•

our ability to maintain our qualification as a RIC and as a BDC;

•

the ability of Tamarix LP, OFS Capital WM and any other portfolio companies to make distributions enabling us to meet RIC requirements;

•

our ability to raise capital as a BDC;

•

the timing, form and amount of any distributions from our portfolio companies;

•

the impact of a protracted decline in the liquidity of credit markets on our business;

•

the general economy and its impact on the industries in which we invest;

•

uncertain valuations of our portfolio investments; and

•

the effect of new or modified laws or regulations governing our operations.

Although we believe that the assumptions on which these forward-looking statements are based are reasonable, any of those assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. In light of these and other uncertainties, the inclusion of a projection or forward-looking statement in this quarterly report on Form 10-Q should not be regarded as a representation by us that our plans and objectives will be achieved. These risks and uncertainties include, among others, those described or identified in “Item 1A. Risk Factors” in our annual report on Form 10-K. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this quarterly report on Form 10-Q.

We have based the forward-looking statements on information available to us on the date of this quarterly report on Form 10-Q. Except as required by the federal securities laws, we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise. You are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. The forward-looking statements and projections contained in this quarterly report on Form 10-Q are excluded from the safe harbor protection provided by Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.

The following analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes thereto contained elsewhere in this quarterly report on Form 10-Q.

Overview

We are an externally managed, closed-end, non-diversified management investment company formed in March 2001. Our investment objective is to provide our stockholders with both current income and capital appreciation primarily through debt investments and, to a lesser extent, equity investments. We intend to pursue an investment strategy focused primarily on investments in middle-market companies in the United States.

In connection with our initial public offering, or IPO, on November 7, 2012, we converted from a limited liability company to a corporation, as a result of which the sole membership interest held by OFSAM prior to the conversion was exchanged for 2,912,024 shares of our common stock. In connection with our IPO, we elected to be treated as a BDC under the Investment Company Act of 1940, as amended, or the 1940 Act. On November 14, 2012, we completed our IPO, selling 6,666,667 shares of our common stock at a public offering price of $15 per share and raising $100 million in gross proceeds. We incurred approximately $6.2 million of sales load and $5.8 million of offering related costs in connection with our IPO. We utilized approximately $90 million of our IPO proceeds to pay down the senior secured revolving credit facility that OFS Capital WM, our wholly owned subsidiary, entered into with Wells Fargo Bank, N.A., or Wells Fargo, and Madison Capital Funding LLC, a subsidiary of New York Life Investments, or Madison Capital, to finance its business, which we refer to as the OFS Capital WM Facility. The OFS Capital WM Facility indebtedness repaid included approximately $48.0 million of Class A loans and approximately $42.0 million of Class B loans.

Although we will continue to focus on investments in senior secured loans, we also intend to expand into additional asset classes in which OFS Advisor’s investment professionals have expertise, including investments in unitranche, second-lien and mezzanine loans and, to a lesser extent, warrants and other minority equity securities. Initially, we expect that our senior secured loan investments will principally be made through on-balance sheet special purpose vehicles, while our unitranche, second lien and mezzanine loans will be made by us directly or by Tamarix LP. We expect our investments in the equity securities of these companies, such as warrants, preferred stock, common stock and other equity interests, will principally be made in conjunction with our debt investments, although we currently anticipate that no more than 5% of our portfolio will consist of equity investments in middle-market companies that do not pay a regular dividend. Generally, we do not expect to make investments in companies or securities that OFS Advisor determines to be distressed investments (such as discounted debt instruments that have either experienced a default or have a significant potential for default), other than follow-on investments in portfolio companies of ours.

A substantial portion of our business will focus on the direct origination and sourcing of investments through portfolio companies or their financial sponsors or other owners or intermediaries. We expect our middle-market investments to range generally from $5 million to $25 million each, although we expect that this investment size will vary proportionately with the size of our capital base.

Our investment activities are managed by OFS Advisor and supervised by our board of directors, a majority of whom are independent of us, OFS Advisor and its affiliates. Under the investment advisory agreement between us and OFS Advisor, or the Investment Advisory Agreement, we have agreed to pay OFS Advisor an annual base management fee based on the average value of total assets (other than cash and cash equivalents but including assets purchased with borrowed amounts and including assets owned by any consolidated entity), as well as an incentive fee based on our investment performance. We have also entered into an administration agreement, or the Administration Agreement, with OFS Capital Services, LLC, or OFS Services. Under the Administration Agreement, we have agreed to reimburse OFS Services for our allocable portion (subject to the review and approval of our independent directors) of overhead and other expenses incurred by OFS Services in performing its obligations under the Administration Agreement.

As a BDC, we must not acquire any assets other than “qualifying assets” specified in the 1940 Act unless, at the time the acquisition is made, at least 70% of our total assets are qualifying assets (with certain limited exceptions). Qualifying assets include investments in “eligible portfolio companies.” Under the relevant SEC rules, the term “eligible portfolio company” includes all private companies, companies whose securities are not listed on a national securities exchange, and certain public companies that have listed their securities on a national securities exchange and have a market capitalization of less than $250 million, in each case organized in the United States.

We have elected to be treated for tax purposes as a RIC under the Code. To qualify as a RIC, we must, among other things, meet certain source-of-income and assets diversification requirements. Pursuant to that election, we generally will not have to pay corporate-level taxes on any income we distribute to our shareholders.

As of September 30, 2013, our net asset value was approximately $139.2 million, or approximately $14.46 per share, and our portfolio included debt investments in 55 portfolio companies as well as our equity investment in Tamarix LP. As of September 30, 2013, our investment portfolio consisted of outstanding loans of approximately $213.9 million in aggregate principal amount, all of which were senior secured loans, as well as an equity investment of approximately $11.3 million at fair value.

Recent Developments and Other Factors Affecting Comparability

BDC Conversion. On November 7, 2012, OFS Capital, LLC converted into a Delaware corporation, OFS Capital Corporation, and the outstanding limited liability company interest in OFS Capital, LLC was converted into 2,912,024 shares of common stock in OFS Capital Corporation. As part of the BDC Conversion, OFSAM was issued an aggregate of 2,912,024 shares of common stock in OFS Capital Corporation in exchange for its limited liability company interest in OFS Capital, LLC at an average estimated equivalent price of $19.14 per share. Upon completion of our IPO and at September 30, 2013, OFSAM owned an interest of 30.4% and 30.6%, respectively, in us.

Pre-IPO Tamarix Transactions. Prior to May 10, 2012, we were deemed to be the primary beneficiary of Tamarix LP and, therefore, in accordance with Accounting Standards Codification Topic 810, or ASC Topic 810, the financial statements of Tamarix LP were consolidated with ours. On May 10, 2012, as a result of Tamarix LP’s receipt of an SBIC license, we became a 68.4% limited partner in Tamarix LP and were deemed, under the applicable accounting literature, to continue to hold a controlling financial interest in Tamarix LP, as described more fully in our financial statements. Accordingly, we continued to consolidate the financial statements of Tamarix LP with ours at June 30, 2012. On July 27, 2012, however, Tamarix LP repaid its loans together with accrued interest due to us in an aggregate amount of approximately $16.6 million, and the three investment professionals of Tamarix GP resigned from our affiliated entity. As a result, effective as of July 27, 2012, we deconsolidated Tamarix LP’s financial statements from our own, and accounted for our investment in Tamarix LP under the equity method of accounting (“Tamarix Deconsolidation”). Commencing November 8, 2012, upon our BDC Conversion, we account for our investment in Tamarix LP at fair value.

Acquisition of Tamarix LP & Tamarix GP Interests. It is our intention to seek to acquire all of the limited partnership interests in Tamarix LP and all of the ownership interests in Tamarix GP that are currently owned or subscribed for by other persons, which would result in Tamarix LP becoming our wholly-owned subsidiary and, as such, a “drop-down” SBIC. As of the date of this filing, we own approximately 67.5% of the limited partnership interests of Tamarix LP and have reached an agreement to acquire all of the remaining limited partnership interests. Third-party commitments total approximately $12 million, with less than half of those commitments currently funded. We also intend to acquire all of the membership interests in Tamarix GP. The entire Tamarix investment team would be retained by a subsidiary of OFSAM. Acquiring the limited partnership interests in Tamarix LP and the membership interests in Tamarix GP will require further approval from the SBA, and a request for such approval is pending. We cannot assure shareholders that the SBA will grant the necessary further approval. In the event that the SBA does not approve the acquisition, we would still benefit from our significant economic interest in Tamarix LP—currently we have subscribed for $24.9 million out of a total of $36.9 million committed and partially funded commitments in Tamarix LP (giving us 67.5% of the limited partnership interests) and have a non-controlling interest in Tamarix GP—as well as our relationship with the investment professionals on the investment committee of Tamarix GP. If we are successful in acquiring all of the limited partnership interests in Tamarix LP and all of the ownership interests in Tamarix GP that are currently owned or subscribed for by other persons, we would once again consolidate Tamarix LP’s financial statements into our financial statements.

March 2012 OFS Capital WM Facility Amendments. Prior to the amendments to the OFS Capital WM Facility completed in March 2012, under generally accepted accounting principles, we did not consolidate OFS Capital WM’s financial statements into our financial statements, as we determined in accordance with ASC Topic 810 that, despite our owning 100% of the equity interests of OFS Capital WM, the loan manager, Madison Capital, was the primary beneficiary of OFS Capital WM. Therefore, prior to March 30, 2012, we recorded our equity interest in OFS Capital WM in our financial statements but did not consolidate its financial statements with our own.

As a result of the amendments to the OFS Capital WM Facility completed in March 2012, OFS Capital succeeded Madison Capital to the controlling financial interest in OFS Capital WM. In light of this and other factors, we have consolidated the financial statements of OFS Capital WM into our financial statements as of March 30, 2012. The amendments to the OFS Capital WM Facility completed in March 2012 were entered into in light of OFS Capital WM having made investments that utilized the substantial majority of its borrowing capacity under the OFS Capital WM Facility. Accordingly, it was determined that the management of an existing portfolio of investment assets, as opposed to buying and originating activities, would constitute the activities that most significantly impact OFS Capital WM’s economic performance.

Critical Accounting Policies

The preparation of financial statements and related disclosures in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and revenues and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following items as critical accounting policies:

Valuation of Portfolio Investments.

The most significant estimate inherent in the preparation of our consolidated financial statements is the valuation of investments and the related amounts of unrealized appreciation and depreciation of investments recorded.

Our investments are carried at fair value in accordance with the 1940 Act and ASC Topic 820 Fair Value Measurements and Disclosures, or ASC Topic 820. At September 30, 2013, approximately 96% of the Company’s total assets represented investments in portfolio companies that are valued at fair value by the board of directors. Value, as defined in Section 2(a)(41) of the 1940 Act, is (i) the market price for those securities for which a market quotation is readily available and (ii) for all other securities and assets, fair value as determined in good faith by the board of directors. Our debt securities are primarily invested in middle market companies whose securities are not publicly traded. Our investments in these portfolio companies are generally considered Level 3 assets under ASC Topic 820 because the inputs used to value the investments are generally unobservable. As such, we value substantially all of our investments at fair value as determined in good faith by our board of directors pursuant to a consistent valuation policy in accordance with the provisions of ASC Topic 820 and the 1940 Act. Due to the inherent uncertainty in determining the fair value of investments that do not have a readily available market value, the fair value of our investments determined in good faith by our board of directors may differ significantly from the value that would have been used had a readily available market existed for such investments, and the differences could be material.

Our policies relating to the valuation of our portfolio investments are as follows:

Investments for which sufficient market quotations are readily available are valued at such market quotations. We may also obtain indicative prices with respect to certain of our investments from pricing services or brokers or dealers in order to value such investments. We expect that there will not be a readily available market value for many of our investments; those debt and equity securities that are not publicly traded or whose market prices are not readily available are valued at fair value as determined in good faith by the board of directors. We value such investments at fair value as determined in good faith by our board of directors using a documented valuation policy and a consistently applied valuation process. We expect that our valuation of each of our assets for which sufficient market quotations are not readily available will be reviewed by one or more independent third-party valuation firms at least once every 12 months.

Our board of directors is ultimately and solely responsible for determining the fair value of the portfolio investments that are not publicly traded, whose market prices are not readily available on a quarterly basis or any other situation where portfolio investments require a fair value determination.

With respect to investments for which sufficient market quotations are not readily available or for which no or an insufficient number of indicative prices from pricing services or brokers or dealers have been received, our board of directors will undertake, on a quarterly basis, unless otherwise noted, a multi-step valuation process, as described below:

•

For each debt investment, a basic credit rating review process will be completed. The risk rating on every credit facility will be reviewed and either reaffirmed or revised by the investment committee of OFS Advisor. This process will establish base information for the quarterly valuation process.

•

Each portfolio company or investment will be valued by an investment professional.

•

Preliminary valuation conclusions will then be documented and discussed with individual members of the investment committee.

•

The preliminary valuations will then be submitted to the investment committee for ratification.

•

Third-party valuation firm(s) will be engaged to provide valuation services as requested, by reviewing the investment committee’s preliminary valuations. The investment committee’s preliminary fair value conclusions on each of our assets for which sufficient market quotations are not readily available will be reviewed and assessed by a third-party valuation firm at least once in every 12-month period, and more often as determined by our board of directors or required by our valuation policy. Such valuation assessment may be in the form of positive assurance, range of values or other valuation method based on the discretion of our board of directors.

•

Our board of directors will discuss valuations and determine the fair value of each investment in the portfolio in good faith based on the input of OFS Advisor and, where appropriate, the respective independent valuation firm(s).

The types of factors that we may take into account in fair valuing our investments include, as relevant, the nature and realizable value of any collateral, the portfolio company’s ability to make payments and its earnings and discounted cash flow, the markets in which the portfolio company does business, comparison to publicly traded securities and other relevant factors.

Determination of fair value involves subjective judgments and estimates. Accordingly, the notes to our financial statements will express the uncertainty with respect to the possible effect of such valuations, and any change in such valuations, on our financial statements.

Revenue Recognition. Our revenue recognition policies are as follows:

Investments and Related Investment Income: We account for investment transactions on a trade date basis. Our board of directors determines, in good faith, the fair value of each investment in our portfolio. Interest is recognized on an accrual basis. For investments with contractual payment-in-kind (“PIK”) interest, which represents contractual interest accrued and added to the principal balance that generally becomes due at maturity, we will not accrue PIK interest if the portfolio company valuation indicates that PIK interest is not collectible. Realized gains or losses on investments will be measured by the difference between the net proceeds from the disposition and the cost basis of investment, without regard to unrealized gains or losses previously recognized. We report changes in the fair value of investments that are measured at fair value as a component of the net change in unrealized appreciation (depreciation) on non-affiliate and affiliate investments in our consolidated statements of operations.

Non-accrual. We place loans on non-accrual status when principal and interest payments are past due 90 days or more or when there is reasonable doubt that we will collect principal or interest. Accrued interest is generally reversed when a loan is placed on non-accrual. Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management’s judgment. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in our management’s judgment, is likely to remain current. There was one non-accrual loan with a fair value of approximately $2.1 million at September 30, 2013. There were no non-accrual loans at December 31, 2012.

Portfolio Composition and Investment Activity

The total fair value of our investments was approximately $219.3 million at September 30, 2013 and approximately $232.2 million at December 31, 2012. As of September 30, 2013, the investment portfolio held by Tamarix LP consisted of outstanding loans of approximately $25.9 million in aggregate principal amount and equity investments of approximately $4.9 million at fair value. For the nine months ended September 30, 2013, OFS Capital WM closed debt investments with seven companies with an aggregate principal balance of approximately $28.9 million, and Tamarix LP closed five investments with three portfolio companies. Tamarix LP’s five new investments consist of two debt investments with a total face value of $8.6 million and three equity investments purchased for $0.4 million in total. For the year ended December 31, 2012, OFS Capital WM closed debt investments with 24 companies with an aggregate face value of approximately $91.0 million, and Tamarix LP closed an investment with one portfolio company with a face value of approximately $3.3 million.

We categorize debt investments into the following risk categories based on relevant information about the ability of borrowers to service their debt:

1 (Low Risk) – A risk rated 1, or Low Risk, credit is a credit that has most satisfactory asset quality and liquidity, as well as good leverage capacity. It maintains predictable and strong cash flows from operations. The trends and outlook for the credit’s operations, balance sheet, and industry are neutral to favorable. Collateral, if appropriate, has maintained value and would be capable of being liquidated on a timely basis. Overall a 1 rated credit would be considered to be of investment grade quality.

2 (Below Average Risk) – A risk rated 2, or Below Average Risk, credit is a credit that has acceptable asset quality, moderate excess liquidity, modest leverage capacity. It could have some financial/non-financial weaknesses which are offset by strengths; however, the credit demonstrates an ample current cash flow from operations. The trends and outlook for the credit’s operations, balance sheet, and industry are generally positive or neutral to somewhat negative. Collateral, if appropriate, has maintained value and would be capable of being liquidated successfully on a timely basis.

3 (Average) – A risk rated 3, or Average, credit is a credit that has acceptable asset quality, somewhat strained liquidity, minimal leverage capacity. It is at times characterized by just acceptable cash flows from operations. Under adverse market conditions, carrying the current debt service could pose difficulties for the borrower. The trends and conditions of the credit’s operations and balance sheet are neutral to slightly negative.

4 (Special Mention) – A risk rated 4, or Special Mention, credit is a credit with no apparent loss of principal or interest envisioned. Nonetheless, it possesses credit deficiencies or potential weaknesses which deserve management’s close and continued attention. The credit’s operations and/or balance sheet have demonstrated an adverse trend or deterioration which, while serious, has not reached the point where the liquidation of debt is jeopardized. These weaknesses are generally considered correctable by the borrower in the normal course of business but may if not checked or corrected, weaken the asset or inadequately protect our credit position.

5 (Substandard) – A risk rated 5, or Substandard, credit is a credit inadequately protected by the current enterprise value or paying capacity of the obligor or of the collateral, if any. These credits have well-defined weaknesses based upon objective evidence, such as recurring or significant decreases in revenues and cash flows. These assets are characterized by the possibility that we may sustain loss if the deficiencies are not corrected. The possibility that liquidation would not be timely (e.g. bankruptcy or foreclosure) requires a Substandard classification even if there is little likelihood of loss.

6 (Doubtful) – A risk rated 6, or Doubtful, credit is a credit with all the weaknesses inherent in those classified as Substandard, with the additional factor that the weaknesses are pronounced to the point that collection or liquidation in full, on the basis of currently existing facts, conditions and values is deemed uncertain. The possibility of loss on a Doubtful asset is high but, because of certain important and reasonably specific pending factors which may strengthen the asset, its classification as an estimated loss is deferred until its more exact status can be determined.

7 (Loss) – A risk rated 7, or Loss, credit is a credit considered almost fully uncollectible and of such little value that its continuance as an asset is not warranted. It is generally a credit that is no longer supported by an operating company, a credit where the majority of our assets have been liquidated or sold and a few assets remain to be sold over many months or even years, or a credit where the remaining collections are expected to be minimal.

The following table shows the classification of our debt investments portfolio by credit rating as of September 30, 2013 and December 31, 2012:

	September 30, 2013					December 31, 2012
	Debt					Debt
	Investments,		% of Debt			Investments,		% of Debt
	at Fair Value		Investments			at Fair Value		Investments
Credit Rating	(Dollor amounts in thousands)
1	$	-		0.0	%	$	-		0.0	%
2		-		0.0	%		-		0.0	%
3		197,455		94.9	%		211,114		92.8	%
4		8,439		4.1	%		16,428		7.2	%
5		2,081		1.0	%		-		0.0	%
6		-		0.0	%		-		0.0	%
7		-		0.0	%		-		0.0	%
	$	207,975		100.0	%	$	227,542		100.0	%

The following table shows the cost and fair value of our portfolio of investments by asset class as of September 30, 2013 and December 31, 2012, respectively.

	As of September 30,				As of December 31,
	2013				2012
	Cost		Fair Value		Cost		Fair Value
	(Amounts in thousands)
Senior secured
Performing	$	207,673	$	205,894	$	231,781	$	227,542
Non-accrual		3,988		2,081		-		-
Unitranche
Performing		-		-		-		-
Non-accrual		-		-		-		-
Second-Lien
Performing		-		-		-		-
Non-accrual		-		-		-		-
Mezzanine
Performing		-		-		-		-
Non-accrual		-		-		-		-
Unsecured
Performing		-		-		-		-
Non-accrual		-		-		-		-
Equity Investments		10,115		11,322		5,049		4,657
Total	$	221,776	$	219,297	$	236,830	$	232,199

As of September 30, 2013 and December 31, 2012, the weighted average yield to fair value of our debt investments was approximately 7.21% and 7.64%, respectively. Throughout this document, the weighted average yield on debt investments at fair value is computed as (a) total annual stated interest on accruing loans plus the annualized amortization of deferred loan origination fees and accretion of original issue discount, or OID, divided by (b) total debt investments at fair value (with any unamortized premium or discount accounted for at the time of loan repayment). The weighted average yield on debt investments at fair value is computed as of the balance sheet date and excludes assets on non-accrual status as of such date.

As of September 30, 2013, floating rate loans comprised our entire debt investment portfolio. However, in accordance with our investment strategy, we expect that over time the proportion of fixed rate debt investments in our portfolio will increase.

Our level of investment activity may vary substantially from period to period depending on various factors, including, but not limited to, the amount of debt and equity capital available to middle market companies, the level of merger and acquisition activity, general economic environment and the competitive environment for the types of investments we make.

Results of Operations

Key Financial Measures

The following is a discussion of the key financial measures that management employs in reviewing the performance of our operations.

Revenues. We generate revenue in the form of interest income on debt investments and capital gains and distributions, if any, from our investment securities in portfolio companies. Our debt investments typically have a term of three to eight years and bear interest at fixed and floating rates. As of September 30, 2013, floating rate loans comprised 100% of our current debt investment portfolio; however, in accordance with our investment strategy, we expect that over time the proportion of fixed rate loans will increase. In some instances, we receive payments on our debt investments based on scheduled amortization of the outstanding balances. In addition, we anticipate receiving repayments of some of our debt investments prior to their scheduled maturity date. The frequency or volume of these repayments may fluctuate significantly from period to period. On occasion, our portfolio activity may also reflect the proceeds of sales of securities. In some cases, our investments will provide for deferred interest payments or PIK interest (meaning interest paid in the form of additional principal amount of the loan instead of in cash). In addition, we may generate revenue in the form of commitment fees, origination and sourcing fees, structuring or due diligence fees, fees for providing managerial assistance, and consulting fees. Loan origination and sourcing fees, OID, and market discount or premium will be capitalized, and we will accrete or amortize such amounts as interest income. We record prepayment premiums on loans as interest income. When we receive principal payments on a loan in an amount that exceeds its carrying value, we will also record the excess principal payment as income. Dividend income, if any, will be recognized on an accrual basis to the extent that we expect to collect such amounts.

Expenses. Our primary operating expenses include interest expense due under the OFS Capital WM Facility, the payment of fees to OFS Advisor under the Investment Advisory Agreement, and our allocable portion of overhead expenses under the Administration Agreement and other operating costs described below. Additionally, we will pay interest expense on any outstanding debt under any new credit facility or other debt instrument we may enter into. We will bear all other out-of-pocket costs and expenses of our operations and transactions, whether incurred by us directly or on our behalf by a third party, including:

•

the cost of calculating our net asset value, including the cost of any third-party valuation services;

•

the cost of effecting sales and repurchases of shares of our common stock and other securities;

•

fees payable to third parties relating to making investments, including out-of-pocket fees and expenses associated with performing due diligence and reviews of prospective investments;

•

transfer agent and custodial fees;

•

out-of-pocket fees and expenses associated with marketing efforts;

•

federal and state registration fees and any stock exchange listing fees;

•

U.S. federal, state and local taxes;

•

independent directors’ fees and expenses;

•

brokerage commissions;

•

fidelity bond, directors’ and officers’ liability insurance and other insurance premiums;

•

direct costs, such as printing, mailing and long-distance telephone;

•

fees and expenses associated with independent audits and outside legal costs;

•

costs associated with our reporting and compliance obligations under the 1940 Act and other applicable U.S. federal and state securities laws; and

•

other expenses incurred by either OFS Services or us in connection with administering our business, including payments under the Administration Agreement that will be based upon our allocable portion of overhead.

We do not believe that our historical operating performance is necessarily indicative of the results of operations we expect to report in future periods. Prior to the completion of our initial public offering, we completed several significant corporate transactions, including the Tamarix Deconsolidation and the March 2012 OFS Capital WM Facility Amendments, as described in more detail under “Recent Developments and Other Factors Affecting Comparability.” We also intend to pursue a strategy that is focused primarily on investments in middle-market companies in the United States, including investments in senior secured, unitranche, second-lien and mezzanine loans and, to a lesser extent, warrants and other minority equity securities, which differs to some degree from our historical investment concentration, which was in senior secured loans to middle-market companies in the United States. Moreover, as a BDC and a RIC, we will also be subject to certain constraints on our operations, including, but not limited to, limitations imposed by the 1940 Act and the Code, to which we were not previously subject. In addition, Tamarix LP is subject to regulation and oversight by the SBA. For the reasons described above, the results of operations described below may not necessarily be indicative of the results we expect to report in future periods.

Comparison of the three and nine month periods ended September 30, 2013 (unaudited) and September30, 2012 (unaudited)

Consolidated operating results for the three and nine month periods ended September 30, 2013 and September 30, 2012, are as follows:

	Three Months Ended					Nine Months Ended
	September 30					September 30
	2013			2012		2013		2012
	(Amounts in thousands)
Total investment income	$	4,017		$	4,035	$	12,618	$	9,197
Total expenses		2,589			2,598		8,282		6,407
Net investment income		1,428			1,437		4,336		2,790
Net realized and unrealized gain (loss) on investments		(1,062	)		1,081		2,158		(1,023	)
Total other income prior to becoming a business development company		-			442		-		3,113
Cumulative effect of accounting change		-			-		-		570
Net increase in net assets resulting from operations	$	366		$	2,960	$	6,494	$	5,450

Net income can vary substantially from period to period for various reasons, including the recognition of realized gains and losses and unrealized appreciation and depreciation. As a result, comparisons of net income may not be meaningful.

Investment Income

	Three Months Ended				Nine Months Ended
	September 30				September 30
	2013		2012		2013		2012
	(Amounts in thousands)
Interest income from non-affiliate investments	$	4,017	$	4,020	$	12,618	$	9,091
Dividend and fee income		-		15		-		106
Net investment income	$	4,017	$	4,035	$	12,618	$	9,197

Total investment income was approximately $4.0 million for both the three month period ended September 30, 2013 and the three month period ended September 30, 2012.

Total investment income increased by approximately $3.4 million, or 37%, for the nine month period ended September 30, 2013, as compared to the nine month period ended September 30, 2012. The $3.4 million increase in total investment income was primarily due to nine months of interest income generated by OFS Capital WM during 2013, as compared to six months during 2012, as a result of our consolidation of OFS Capital WM’s results of operations effective April 1, 2012.

Expenses

	Three Months Ended				Nine Months Ended
	September 30				September 30
	2013		2012		2013		2012
	(Amounts in thousands)
Interest expense	$	821	$	1,511	$	2,530	$	2,956
Amortization of deferred financing closing costs		168		144		803		287
Management fees		744		591		2,345		1,555
Management fees - other related parties		-		151		-		627
Professional fees		418		86		1,177		489
Administrative fee		200		-		657		-
General and administrative expenses		238		115		770		493
Total expenses	$	2,589	$	2,598	$	8,282	$	6,407

Total expenses were $2.6 million for both the three month period ended September 30, 2013 and the three month period ended September 30, 2012. Interest expense decreased by approximately $0.7 million for the three month period ended September 30, 2013, compared to the three month period ended September 30, 2012, primarily due to the decrease in the outstanding balance on the revolving lines of credit. Management fees expense increased by approximately $0.2 million for the three month period ended September 30, 2013 compared to the three month period ended September 30, 2012, which was attributable to an increase in management fee expense we incurred to our investment advisor during the three months ended September 30, 2013 in the amount of $0.2 million. We incurred management fees – other related parties of approximately $0.2 million, during the three month period ended September 30, 2012, which represented management fee expense incurred by Tamarix LP to its investment manager during the three months ended September 30, 2012, while it was consolidated into our financial statements through July 27, 2012. Professional fees and general and administrative expenses increased by approximately $0.5 million for the three month period ended September 30, 2013 compared to the three month period ended September 30, 2012, due to our increased costs as a public company and legal fees incurred in connection with the acquisition of the remaining Tamarix LP and Tamarix GP interests. We incurred an administrative fee expense of approximately $0.2 million during the three months ended September 30, 2013, which was related to costs incurred under the Administration Agreement subsequent to our IPO.

Total expenses increased by approximately $1.9 million, or 29%, for the nine month period ended September 30, 2013 as compared with the nine month period ended September 30, 2012. Interest expense decreased by approximately $0.4 million for the nine month period ended September 30, 2013 compared to the nine month period ended September 30, 2012, primarily due to the decrease in the outstanding balance on the revolving lines of credit, which was partially offset by the higher interest expense we incurred for the nine month period ended September 30, 2013 compared to only six months of interest expense in the prior period as a result of our consolidation of OFS Capital WM statement of operations effective April 1, 2012. Amortization of deferred financing costs increased by $0.5 million for the nine month period ended September 30, 2013 compared to the nine month period ended September 30, 2012, due to the termination of the Class B loan facility of OFS Capital WM in January 2013 and the resulting write off of $0.3 million in unamortized deferred financing costs. Management fees expense increased by approximately $0.8 million for the nine month period ended September 30, 2013 compared to the nine month period ended September 30, 2012, which was attributable to (1) an increase in management fee expense we incurred to our investment advisor during the nine months ended September 30, 2013 in the amount of $0.5 million, and (2) nine months of management fee expense incurred by OFS Capital WM to its loan manager for 2013 compared to only six months of management fee expense for the period April 1, 2012 through September 30, 2012. We incurred management fees – other related parties of approximately $0.6 million during the nine month period ended September 30, 2012, which represented management fee expense incurred by Tamarix LP to its investment manager during the nine months ended September 30, 2012, while it was consolidated into our financial statements through July 27, 2012. We incurred an administrative fee expense of approximately $0.7 million during the nine months ended September 30, 2013. Professional fees and general and administrative expenses increased by approximately $1.0 million for the nine month period ended September 30, 2013 compared to the nine month period ended September 30, 2012, due to our increased costs as a public company, legal fees incurred in connection with the acquisition of the remaining Tamarix LP and Tamarix GP interests, and our consolidation of OFS Capital WM’s statement of operations effective April 1, 2012.

Net Realized and Unrealized Gains (Losses) on Investments

	Three Months Ended						Nine Months Ended
	September 30						September 30
	2013			2012			2013		2012
	(Amounts in thousands)
Net realized gain (loss) on non-affiliate investments	$	-		$	(92	)	$	5	$	(1,257	)
Net change in unrealized depreciation on non-affiliate investments		(1,501	)		1,173			554		234
Net change in unrealized appreciation on affiliate investments		439			-			1,599		-
Net realized and unrealized gain (loss) on investments	$	(1,062	)	$	1,081		$	2,158	$	(1,023	)

For the three month period ended September 30, 2013, we recorded total net unrealized loss on investments in the amount of approximately $1.1 million, consisting of approximately $1.5 million of net unrealized loss on non-affiliate investments and $0.4 million of net unrealized gain on affiliate investments. For the three month period ended September 30, 2012, we recorded total net realized and unrealized gain on investments in the amount of approximately $1.1 million, consisting of approximately $0.1 million of net realized loss on non-affiliate investments, which represented the net realized loss we incurred from the sale of a debt investment, and $1.2 million of net unrealized gain on non-affiliate investments.

For the nine month period ended September 30, 2013, we recorded total net realized and unrealized gain on investments in the amount of approximately $2.2 million, consisting primarily of approximately $0.6 million of net unrealized gain on non-affiliate investments and $1.6 million of net unrealized gain on affiliate investments. For the nine month period ended September 30, 2012, we recorded total net realized and unrealized loss on investments in the amount of approximately $1.0 million, consisting of approximately $1.2 million of net realized loss on non-affiliate investments, which represented the net realized loss we incurred from the sales of debt investments, and $0.2 million of net unrealized gain on non-affiliate investments.

Other Income (Loss) Prior to Becoming a Business Development Company

	Three Months Ended				Nine Months Ended
	September 30				September 30
	2013		2012		2013		2012
	(Amounts in thousands)
Income from equity interest in OFS Capital WM	$	-	$	-	$	-	$	2,645
Income from equity interest in Tamarix LP		-		378		-		378
Net loss attributable to non-controlling interests		-		32		-		61
Other loss		-		32		-		29
Total other income prior to becoming a business development company	$	-	$	442	$	-	$	3,113

We generated approximately $0.4 million and $3.1 million, respectively, of total other income prior to becoming a BDC for the three and nine month periods ended September 30, 2012. Our recording of other income for the three and nine month periods ended September 30, 2012 was primarily due to (1) our equity interest income in Tamarix LP in the amount of $0.4 million for the period July 27, 2012 through September 30, 2012, post deconsolidation of Tamarix LP, and (2) our equity interest income in OFS Capital WM in the amount of $2.6 million for the period January 1, 2012 through March 31, 2012, prior to our consolidation of OFS Capital WM.

Financial Condition, Liquidity and Capital Resources

At September 30, 2013 and December 31, 2012, we had cash and cash equivalents of approximately $6.8 million and $8.3 million, respectively. Cash provided by operating activities was approximately $21.1 million for the nine months ended September 30, 2013, and cash used in operating activities was approximately $8.7 million for the nine months ended September 30, 2012.

We utilized $90 million of our IPO proceeds to pay down the OFS Capital WM Facility in November 2012. The OFS Capital WM Facility indebtedness repaid included approximately $48.0 million of Class A loans and approximately $42.0 million of Class B loans. In January 2013, we terminated the Class B facility. Outstanding Class A loans accrue interest at a rate per annum equal to LIBOR plus 2.75% (or 4.75% if an event of default has occurred). The Class A loans mature on December 31, 2016, which maturity date will be extended by one year if the reinvestment period is extended by one year.

We generated cash in 2012 primarily from the net proceeds of our IPO and intend to generate additional cash flows from operations, distributions from equity investments and future borrowings, including borrowings by OFS Capital WM pursuant to the OFS Capital WM Facility, and through future offerings of securities. Following the $90 million repayment on the OFS Capital WM Facility, we had in excess of $90 million of borrowing capacity. We may seek a credit facility to finance investments and working capital requirements. There can be no assurance that we will be able to obtain such financing on favorable terms or at all. In the future, we may also seek to finance all or portions of our portfolio through on-balance sheet special purpose vehicles. To securitize investments, we would likely create a subsidiary and contribute a pool of investments to the subsidiary. We or the subsidiary would then sell debt or equity interests in the subsidiary to purchasers and we would retain all or a portion of the equity in the subsidiary. Our primary use of funds would be investments in our targeted asset classes, interest payments on any indebtedness, and cash distributions to holders of our common stock.

Although we expect to fund the growth of our investment portfolio from borrowing under the OFS Capital WM Facility, future equity offerings, including our dividend reinvestment plan, and issuances of senior securities or future borrowings, to the extent permitted by the 1940 Act, we cannot assure shareholders that our plans to raise capital will be successful. In addition, we intend to distribute to our stockholders substantially all of our taxable income in order to satisfy the requirements applicable to RICs under Subchapter M of the Code. Consequently, we may not have the funds available to make new investments or additional investments in our portfolio companies, or to fund our unfunded commitments to portfolio companies. The illiquidity of our portfolio investments may make it difficult for us to sell these investments when desired and, if we are required to sell these investments, we may realize significantly less than their recorded value.

In addition, as a BDC, we generally are required to meet a coverage ratio of total assets, less liabilities and indebtedness not represented by senior securities, to total senior securities, which include all of our borrowings and any outstanding preferred stock, of at least 200%. This requirement limits the amount that we may borrow. To fund growth in our investment portfolio in the future, we anticipate needing to raise additional capital from various sources, including the equity markets and the securitization or other debt-related markets, which may or may not be available on favorable terms, if at all. Our asset coverage ratio is approximately 264% at September 30, 2013.

The OFS Capital WM Facility

On September 28, 2010, OFS Capital WM entered into a $180.0 million secured revolving credit facility (as amended, from time to time, the “OFS Capital WM Facility”) with Wells Fargo and Madison Capital, with the Class A lenders (initially Wells Fargo) providing up to $135 million in Class A loans and the Class B lenders (initially Madison Capital) providing up to $45 million in Class B loans to OFS Capital WM. In January 2013, OFS Capital WM terminated its $45 million Class B credit facility. The OFS Capital WM Facility is secured by the eligible loans transferred to OFS Capital WM by OFS Capital on September 28, 2010, as well as eligible loan assets subsequently acquired by OFS Capital WM.

Outstanding borrowings on the Class A credit facility are limited to the lesser of (a) the “maximum facility amount” of $135 million and (b) the “borrowing base.” Generally, during the reinvestment period, the borrowing base is equal to the value of the loan assets in OFS Capital WM’s portfolio multiplied by the advance rate of 65% with respect to the Class A loans. After the reinvestment period, the maximum facility amount will be limited to the then outstanding principal amount of Class A loans.

If at any time the amount of Class A loans outstanding exceeds the borrowing base, a borrowing base deficiency will exist. In that event, OFS Capital WM will have three business days to eliminate the deficiency by, among other things, (a) depositing additional cash into the relevant collection account, (b) repaying Class A loans, or (c) pledging additional eligible loan assets. In the case of such a deficiency, we may determine it is in our best interests to make additional capital contributions to OFS Capital WM in the form of cash or additional eligible loan assets to protect the value of our equity investment in OFS Capital WM, and our additional contributions could be material.

Under the OFS Capital WM Facility, the loan manager charges both a senior and subordinated management fee to OFS Capital WM for its services, each at 0.25% per annum of the assigned value of the underlying portfolio investments, plus an accrued fee that is deferred until after the end of the investment period of the portfolio investments. For the three and nine months ended September 30, 2013, we incurred management fee expense of approximately $0.2 million and $0.8 million, respectively, to the loan manager.

On September 28, 2012, the OFS Capital WM Facility was amended. Pursuant to the amendment: (1) the loans were extended to December 31, 2016, and there is a one-year option for extension of the Class A loans upon the approval of the Class A lenders; (2) the reinvestment period was extended to December 31, 2013, which can be further extended by one year with the consent of the lenders; and (3) the accrued interest rate on outstanding Class A loans was amended to LIBOR plus 2.75% per annum. In connection with the amendment, OFS Capital WM incurred financing costs of $0.7 million which, together with the original unamortized deferred financing costs under the OFS Capital WM Facility of $2.4 million at September 28, 2012, are deferred and amortized over the life of the OFS Capital WM Facility.

Off-Balance Sheet Arrangements

We may be a party to financial instruments with off-balance sheet risk in the normal course of our business to meet the financial needs of our portfolio companies. As of September 30, 2013, we had a $1.5 million unused line of credit granted to a borrower. Unused lines of credit involve, to varying degrees, elements of credit risk in excess of the amount recognized in the balance sheet and are not reflected on our balance sheet. In addition, as of September 30, 2013, we had approximately $15.0 million of committed but uncalled equity investment in Tamarix LP.

Contractual Obligations

The following table shows our contractual obligations as of September 30, 2013:

	Payments due by period
			Less than 1						After 5
Contractual Obligations (1)	Total		year		1-3 years		3-5 years		years
	(Amounts in thousands)
Borrowings	$	84,083	$	-	$	-	$	84,083	$	-
Total	$	84,083	$	-	$	-	$	84,083	$	-

(1)

Excludes commitments to extend credit to our portfolio companies.

We have entered into contracts with third parties under which we have material future commitments—the Investment Advisory Agreement, pursuant to which OFS Advisor has agreed to serve as our investment adviser, and the Administration Agreement, pursuant to which OFS Services has agreed to furnish us with the facilities and administrative services necessary to conduct our day-to-day operations.

As a result of the March 2012 OFS Capital WM Facility amendments, we have consolidated OFS Capital WM in our financial statements effective as of March 30, 2012. For more information on the contractual obligations of OFS Capital WM, including the OFS Capital WM Facility, see “Notes to Unaudited Consolidated Financial Statements” contained in Item 1. Financial Statements.

We have subscribed for $24.9 million out of a total of $36.9 million committed and partially funded commitments in Tamarix LP. We have partially funded and may be called upon to fund the balance of our commitment in connection with the operations of Tamarix LP.

Commitments and Contingencies

At September 30, 2013, we had a $1.5 million unused line of credit granted to a borrower. On March 27, 2012, we entered into a new subscription agreement (“Subscription Agreement”) with respect to an investment in Tamarix LP, which superseded prior agreements and was contingent upon issuance of the license from the SBA. Under the terms of the Subscription Agreement, our investment in Tamarix LP will not exceed $25.0 million. On April 2, 2012, OFS Capital funded $1.6 million to Tamarix LP. In March and April 2012, Tamarix LP also received an aggregate of $0.2 million and $0.7 million, respectively, from other investors. These funds, totaling $2.5 million, were called by Tamarix LP as requested by the SBA and would be used as initial capital of Tamarix LP once Tamarix LP received the SBIC license. On May 10, 2012, as a result of Tamarix LP’s receipt of the SBIC license, our equity investment in Tamarix LP was no longer contingent, and our advance to Tamarix LP in the amount of $1.6 million was reclassified as an equity investment in Tamarix LP. In July 2012, we made an additional equity investment of $3.2 million in Tamarix LP. During the nine months ended September 30, 2013, we made two additional equity investments totaling $5.2 million in Tamarix LP. As of September 30, 2013, our committed but uncalled capital investment in Tamarix LP was approximately $15.0 million.

We have reached an agreement to acquire all of the limited partnership interests in Tamarix LP (“Tamarix LP Acquisition”) that we do not already own and, in conjunction therewith, have submitted documentation to the SBA in connection with our plan to convert Tamarix LP into a wholly-owned subsidiary of us. We also intend to acquire all of the remaining membership interests in Tamarix GP (“Tamarix GP Acquisition”). The completion of the Tamarix LP Acquisition and Tamarix GP Acquisition is still subject to the SBA’s approval. If we obtain the necessary approvals from the SBA, we will increase our capital commitment to Tamarix LP, both directly and through Tamarix GP, to $75 million. Depending upon the details of final approvals from the SBA, if such approvals are obtained, the portion of the capital commitment that we will need to fund at the closing of the drop-down of Tamarix LP is expected to range from $40 million to $50 million. In order to fund the capital commitment to Tamarix LP, we may need to sell a portion of our current investments in OFS Capital WM at a time when it is disadvantageous to do so.

From time to time, we are involved in legal proceedings in the normal course of its business. Although the outcome of such litigation cannot be predicted with any certainty, management is of the opinion, based on the advice of legal counsel, that final disposition of any litigation should not have a material adverse effect on our financial position.

In the normal course of business, we enter into contracts and agreements that contain a variety of representations and warranties that provide general indemnifications. Our maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against us that have not occurred. We believe the risk of any material obligation under these indemnifications to be unlikely.

Distributions

We are taxed as a RIC under the Code. Generally, a RIC is entitled to deduct dividends it pays to its shareholders from its income to determine “taxable income.” Taxable income includes our taxable interest, dividend and fee income, and taxable net capital gains. Taxable income generally differs from net income for financial reporting purposes due to temporary and permanent differences in the recognition of income and expenses, and generally excludes net unrealized appreciation or depreciation, as gains or losses are not included in taxable income until they are realized. In addition, gains realized for financial reporting purposes may differ from gains included in taxable income as a result of our election to recognize gains using installment sale treatment, which generally result in the deferment of gains for tax purposes until notes or other amounts, including amounts held in escrow, received as consideration from the sale of investments are collected in cash. Taxable income includes non-cash income, such as changes in accrued and reinvested interest and dividends, which includes contractual PIK interest, and the amortization of discounts and fees. Cash collections of income resulting from contractual PIK interest or the amortization of discounts and fees generally occur upon the repayment of the loans or debt securities that include such items. Non-cash taxable income is reduced by non-cash expenses, such as realized losses and depreciation, and amortization expense.

Our board of directors will maintain a variable dividend policy with the objective of distributing four quarterly distributions in an amount that approximates 90-100% of our taxable quarterly income or potential annual income for a particular year. In addition, at the end of the year, we may also pay an additional special dividend, or fifth dividend, such that we may distribute approximately all of our annual taxable income in the year it was earned, while maintaining the option to spill over our excess taxable income.

The following table summarizes our distributions declared and paid on all shares to date:

Date Declared	Record Date	Payment Date	Amount Per Share
November 26, 2012	January 17, 2013	January 31, 2013	$	0.17	⁽¹⁾
March 26, 2013	April 17, 2013	April 30, 2013	$	0.34
June 25, 2013	July 17, 2013	July 31, 2013	$	0.34
September 25, 2013	October 17, 2013	October 31, 2013	$	0.34

⁽¹⁾

Represents the distribution declared in the specified quarter, which, if prorated for the number of days remaining in the fourth quarter after our IPO in November 2012, would have been $0.34 per share.

We may not be able to achieve operating results that will allow us to make distributions at a specific level or to increase the amount of these distributions from time to time. If we do not distribute a certain percentage of our income annually, we will suffer adverse tax consequences, including possible loss of our status as a regulated investment company. We cannot assure stockholders that they will receive any distributions at a particular level.

Distributions in excess of our current and accumulated earnings and profits generally would be treated first as a return of capital to the extent of the stockholder’s tax basis, and any remaining distributions would be treated as a capital gain. The determination of the tax attributes of our distributions is made annually as of the end of our fiscal year based upon our taxable income for the full year and distributions paid for the full year; therefore, a determination made on a quarterly basis may not be representative of the tax attributes of our annual distributions to stockholders. For the nine months ended September 30, 2013, out of our approximately $9.8 million in dividend distributions, approximately 46% represented ordinary income and net realized capital gain and 54% represented a return of capital.

Each year a statement on Form 1099-DIV identifying the source of the distribution (i.e., paid from ordinary income, paid from net capital gains on the sale of securities, and/or a return of paid-in-capital surplus, which is a nontaxable distribution) is mailed to our U.S. stockholders. To the extent our taxable earnings fall below the total amount of our distributions for that fiscal year, a portion of those distributions may be deemed a tax return of capital to our stockholders.

We maintain an “opt-out” dividend reinvestment plan for our common stockholders. As a result, if we declare a dividend, cash dividends will be automatically reinvested in additional shares of our common stock unless the stockholder specifically “opts out” of the dividend reinvestment plan and chooses to receive cash dividends.

Related Party Transactions

Investment Advisory Agreement

We have entered into an Investment Advisory Agreement with OFS Advisor and will pay OFS Advisor a management fee and incentive fee. Pursuant to the Investment Advisory Agreement with OFS Advisor and subject to the overall supervision of our board of directors and in accordance with the 1940 Act, OFS Advisor provides investment advisory services to us. For providing these services, OFS Advisor receives a fee from us consisting of two components—a base management fee and an incentive fee. From the completion of our initial public offering through October 31, 2013, the base management fee was calculated at an annual rate of 0.875% based on the average value of our total assets (other than cash and cash equivalents but including assets purchased with borrowed amounts and including assets owned by any consolidated entity) at the end of the two most recently completed calendar quarters. Beginning on November 1, 2013, the base management fee is calculated at an annual rate of 1.75% based on the average value of our total assets (other than cash and cash equivalents but including assets purchased with borrowed amounts and including assets owned by any consolidated entity) at the end of the two most recently completed calendar quarters. The base management fee is payable quarterly in arrears. The base management fee expense was approximately $0.5 million and $1.5 million for the three and nine months ended September 30, 2013, respectively.

The incentive fee has two parts. One part is calculated and payable quarterly in arrears based on our pre-incentive fee net investment income for the quarter. “Pre-incentive fee net investment income” means interest income, dividend income and any other income (including any other fees such as commitment, origination and sourcing, structuring, diligence and consulting fees or other fees that we receive from portfolio companies but excluding fees for providing managerial assistance) accrued during the calendar quarter, minus operating expenses for the quarter (including the base management fee, any expenses payable under the Administration Agreement and any interest expense and dividends paid on any outstanding preferred stock, but excluding the incentive fee). Pre-incentive fee net investment income includes, in the case of investments with a deferred interest feature (such as OID, debt instruments with PIK interest and zero coupon securities), accrued income that we have not yet received in cash.

Pre-incentive fee net investment income does not include any realized gains, realized losses, unrealized capital appreciation or unrealized capital depreciation. Because of the structure of the incentive fee, it is possible that we may pay an incentive fee in a quarter where we incur a loss. For example, if we receive pre-incentive fee net investment income in excess of the hurdle rate (as defined below) for a quarter, we will pay the applicable incentive fee even if we have incurred a loss in that quarter due to realized capital losses and unrealized capital depreciation.

Pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets (defined as total assets less indebtedness and before taking into account any incentive fees payable during the period) at the end of the immediately preceding calendar quarter, is compared to a fixed “hurdle rate” of 2.0% per quarter. If market interest rates rise, we may be able to invest our funds in debt instruments that provide for a higher return, which would increase our pre-incentive fee net investment income and make it easier for OFS Advisor to surpass the fixed hurdle rate and receive an incentive fee based on such net investment income. There is no accumulation of amounts on the hurdle rate from quarter to quarter, and accordingly there is no clawback of amounts previously paid if subsequent quarters are below the quarterly hurdle rate. Similarly, there is no delay of payment if prior quarters are below the quarterly hurdle rate.

We pay OFS Advisor an incentive fee with respect to our pre-incentive fee net investment income in each calendar quarter as follows:

•

no incentive fee in any calendar quarter in which the pre-incentive fee net investment income does not exceed the hurdle rate;

•

100% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than 2.5% in any calendar quarter. We refer to this portion of our pre-incentive fee net investment income (which exceeds the hurdle rate but is less than 2.5%) as the “catch-up” provision. The catch-up is meant to provide OFS Advisor with 20.0% of the pre-incentive fee net investment income as if a hurdle rate did not apply, if this pre-incentive fee net investment income exceeds 2.5% in any calendar quarter; and

•

20.0% of the amount of our pre-incentive fee net investment income, if any, that exceeds 2.5% in any calendar quarter.

The second part of the incentive fee (the “Capital Gains Fee”) is determined and payable in arrears as of the end of each calendar year (or, upon termination of the Investment Advisory Agreement, as of the termination date) and is calculated at the end of each applicable year by subtracting (a) the sum of our cumulative aggregate realized capital losses and our aggregate unrealized capital depreciation from (b) our cumulative aggregate realized capital gains. If such amount is positive at the end of such year, then the Capital Gains Fee for such year is equal to 20.0% of such amount, less the aggregate amount of Capital Gains Fees paid in all prior years. If such amount is negative, then there is no Capital Gains Fee for such year.

We did not incur any incentive fee expenses for the three and nine months ended September 30, 2013.

The cumulative aggregate realized capital gains are calculated as the sum of the differences, if positive, between (a) the net sales price of each investment in our portfolio when sold and (b) the accreted or amortized cost basis of such investment.

The cumulative aggregate realized capital losses are calculated as the sum of the amounts by which (a) the net sales price of each investment in our portfolio when sold is less than (b) the accreted or amortized cost basis of such investment.

The aggregate unrealized capital depreciation is calculated as the sum of the differences, if negative, between (a) the valuation of each investment in our portfolio as of the applicable Capital Gains Fee calculation date and (b) the accreted or amortized cost basis of such investment. We accrue the Capital Gains Fee if, on a cumulative basis, the sum of net realized capital gains and (losses) plus net unrealized appreciation and (depreciation) is positive. Unrealized capital appreciation is accrued, but not paid until said appreciation is realized.

License Agreement

We have entered into a license agreement with OFSAM under which OFSAM has agreed to grant us a non-exclusive, royalty-free license to use the name “OFS.”

Administration Agreement

We have entered into an Administration Agreement, pursuant to which OFS Services furnishes us with office facilities, equipment, necessary software licenses and subscriptions and clerical, bookkeeping and record keeping services at such facilities. Under our Administration Agreement, OFS Services performs, or oversees the performance of, our required administrative services, which include, among other things, being responsible for the financial records that we are required to maintain and preparing reports to our stockholders and all other reports and materials required to be filed with the SEC or any other regulatory authority. For the three and nine months ended September 30, 2013, we incurred an administration fee expense of approximately $0.2 million and $0.7 million, respectively.

Staffing Agreement

OFS Advisor is an affiliate of Orchard First Source Capital, Inc., or OFSC, with which it has entered into a Staffing and Corporate Services Agreement, or Staffing Agreement. Under this agreement, OFSC will make available to OFS Advisor experienced investment professionals and access to the senior investment personnel and other resources of OFSC and its affiliates. The Staffing Agreement should provide OFS Advisor with access to deal flow generated by the professionals of OFSC and its affiliates and commits the members of OFS Advisor’s investment committee to serve in that capacity. OFS Advisor intends to capitalize on the significant deal origination and sourcing, credit underwriting, due diligence, investment structuring, execution, portfolio management and monitoring experience of OFSC’s investment professionals.

OFSC also has entered into a Staffing and Corporate Services Agreement with OFS Services. Under this agreement, OFS Services will make available to OFSC the administrative resources of OFS Services.

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

We are subject to financial market risks, including changes in interest rates. As of September 30, 2013, all of our debt investments bore interest at floating interest rates, and we expect that our investment portfolio may in the future include both floating and fixed rate debt investments. The interest rates on our debt investments are usually based on a floating LIBOR, and the debt investments typically contain interest rate re-set provisions that adjust applicable interest rates to current rates on a periodic basis. All of the debt investments in our portfolio as of September 30, 2013 had interest rate floors, which have effectively converted those debt investments to fixed rate debt investments in the current interest rate environment.

In addition, our credit facility has a floating interest rate provision, and we expect that other credit facilities into which we may enter in the future may have floating interest rate provisions.

Assuming that our consolidated balance sheet as of September 30, 2013 were to remain constant, and that we took no actions to alter our existing interest rate sensitivity, the following table shows the annualized impact of hypothetical base rate changes in interest rates.

	Interest		Interest			Net increase
Basis point increase(1)	income		expense			(decrease)
	(Amounts in thousands)
100	$	126	$	(853	)	$	(726	)
200		2,032		(1,705	)		327
300		4,200		(2,558	)		1,642
400		6,367		(3,410	)		2,957
500		8,535		(4,263	)		4,272

(1) A decline in interest rates would not have a material impact on our consolidated financial statements.

Although we believe that the foregoing analysis is indicative of our sensitivity to interest rate changes, it does not adjust for potential changes in the credit market, credit quality, size and composition of the assets in our portfolio, and other business developments, including borrowings under our credit facility, that could affect the net increase in net assets resulting from operations, or net income. Accordingly, no assurances can be given that actual results would not differ materially from the statement above.

We are subject to financial market risks, including changes in interest rates. Changes in interest rates affect both our cost of funding and the valuation of our investment portfolio. Our risk management systems and procedures are designed to identify and analyze our risk, to set appropriate policies and limits, and to continually monitor these risks and limits by means of reliable administrative and information systems and other policies and programs. Our investment portfolio and investment income may be affected by changes in various interest rates, including LIBOR and prime rates.

As of September 30, 2013, all of our outstanding debt investments bore interest at floating rates.

Item 4.

Controls and Procedures

Our Chief Executive Officer and Chief Financial Officer, under the supervision and with the participation of our management, conducted an evaluation of our disclosure controls and procedures, as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). As of the end of the period covered by this quarterly report on Form 10-Q, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

There have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended) that occurred during the quarter ended September 30, 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II—OTHER INFORMATION

Item 1.

Legal Proceedings

We, OFS Advisor and OFS Services, are not currently subject to any material pending or threatened legal proceedings against us as of September 30, 2013. From time to time, we may be a party to certain legal proceedings incidental to the normal course of our business, including the enforcement of our rights under contracts with our portfolio companies. While the outcome of these legal proceedings cannot be predicted with certainty, we do not expect that these proceedings will have a material effect upon our business, financial condition or results of operations.

Item 1A.

Risk Factors

In addition to the risks discussed below, important risk factors that could cause results or events to differ from current expectations are described in Part I, Item 1A “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2012.

We may not obtain, in a timely manner, or at all, the necessary approvals requested from the SBA in connection with our proposed acquisition of the ownership interests in Tamarix LP and Tamarix GP that we do not already own.

Tamarix LP has received an SBIC license to operate as a “stand-alone” entity. Additional approvals of the SBA will be required in connection with our proposed acquisition of all of the ownership interests in Tamarix LP and Tamarix GP that we do not already own due to the fact that, following such acquisition, Tamarix LP would be our wholly-owned subsidiary and, as such, would become a “drop-down” SBIC. Although a request for the necessary approvals is pending with the SBA, no assurances can be given to shareholders as to when, or even whether, such approvals will be granted. In addition, although the holders of the ownership interests in Tamarix LP and Tamarix GP that we do not already own have consented to selling those interests to us, these consents will expire on December 6, 2013. If the SBA does not issue the approvals necessary for us to acquire the remaining ownership interests in Tamarix LP and Tamarix GP, or if such approvals are not issued in a timely manner and the holders of the remaining ownership interests in Tamarix LP and Tamarix GP are unwilling to extend their consents beyond December 6, 2013, our ability to benefit from Tamarix LP’s investment opportunities will be correspondingly limited. In the event we are unable to acquire the remaining ownership interests in Tamarix LP and Tamarix GP, we anticipate that we will invest substantially less in Tamarix LP than we would have otherwise, and no more than our current commitment aggregating $25 million in respect of both entities. While our investment objective and strategy will remain the same, the inability to acquire the remaining ownership interests in Tamarix LP and therefore utilize the full leverage capacity of Tamarix LP will potentially reduce the return on our investments or force us to seek alternative sources of debt financing. An inability to obtain acceptable alternative financing could limit our ability to grow our business and execute our business strategy and could decrease our earnings, if any, which may have an adverse effect on the value of our securities.

We may not receive the exemptive relief requested from the SEC to permit us to exclude the debt of Tamarix LP from our asset coverage test, which may decrease our capacity to fund investments with debt capital.

We have applied for exemptive relief from the SEC to permit us, if we acquire the ownership interest in Tamarix LP and Tamarix GP that we do not already own, to exclude the debt of Tamarix LP guaranteed by the SBA from our 200% asset coverage test under the 1940 Act. No assurances can be given to shareholders as to when, or even whether, we will receive exemptive relief from the SEC. If we do not receive an exemption for this SBA debt, we will have reduced capacity to fund investments with debt capital. As a result, we may not be able to realize fully the benefits of Tamarix LP and may not achieve our investment objective.

If our proposed acquisition of Tamarix LP is approved by the SBA, in connection with the closing of the acquisition, we may need to sell a portion of our investments at a time when it is disadvantageous to do so in order to fund our capital commitment to Tamarix LP.

If the SBA issues the approvals necessary for us to acquire the remaining ownership interests in Tamarix LP and Tamarix GP, we will increase our capital commitment to Tamarix LP, both directly and through Tamarix GP, to $75 million. Depending upon the details of final approvals from the SBA, if such approvals are obtained, the portion of the capital commitment that we will need to fund at the closing of the drop-down of Tamarix LP is expected to range from $40 million to $50 million. In order to fund our capital commitment to Tamarix LP, we may need to sell a portion of our current investments in OFS Capital WM at a time when it is disadvantageous to do so. No assurances can be given that sufficient assets can be sold to meet SBA requirements or that we will be able to obtain a purchase price for those investments that equals or exceeds their respective fair values.

OFS Capital WM’s failure to extend the reinvestment period for its revolving credit facility would have a material adverse effect on its ability to fund additional investments.

To fund its debt investments, OFS Capital WM borrows under its revolving credit facility with Wells Fargo. The reinvestment period under that facility is due to expire on December 31, 2013. Although OFS Capital WM is currently seeking to extend the reinvestment period, its failure to do so would materially limit the capital available to OFS Capital WM to make new investments.

A failure or the perceived risk of a failure to raise the statutory debt limit of the United States could have a material adverse effect on our business, financial condition and results of operations.

As has been widely reported, the United States Treasury Secretary has stated that the federal government may not be able to meet its debt payments in the relatively near future (currently February 2014) unless the federal debt ceiling is raised. If legislation increasing the debt ceiling is not enacted and the debt ceiling is reached, the federal government may stop or delay making payments on its obligations. A failure by Congress to raise the debt limit would increase the risk of default by the United States on its obligations, as well as the risk of other economic dislocations. If the U.S. Government fails to complete its budget process or to provide for a continuing resolution before the expiration of the current continuing resolution (currently January 2014), another federal government shutdown may result. Such a failure or the perceived risk of such a failure consequently could have a material adverse effect on the financial markets and economic conditions in the United States and throughout the world. It could also limit our ability and the ability of our portfolio companies to obtain financing, and it could have a material adverse effect on the valuation of our portfolio companies. Consequently, the continued uncertainty in the general economic environment, including the recent government shutdown and potential debt ceiling implications, as well in specific economies of several individual geographic markets in which our portfolio companies operate, could adversely affect our business, financial condition and results of operations.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

During the nine month period ended September 30, 2013, we issued 48,296 shares of common stock to shareholders in connection with the dividend reinvestment plan. These issuances were not subject to the registration requirements of the Securities Act of 1933, as amended. The aggregate value of the shares of our common stock issued under our dividend reinvestment plan was approximately $685,000.

Item 3.

Defaults Upon Senior Securities

Not applicable.

Item 4.

Mine Safety Disclosures

Not applicable.

Item 5.

Other Information

Not applicable.

Item 6.

Exhibits

Listed below are the exhibits that are filed as part of this report (according to the number assigned to them in Item 601 of Regulation S-K):

Exhibit Number		Description
31.1		Certification of Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended*

31.2		Certification of Chief Financial Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended*

32.1		Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*

32.2		Certificate of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*

Filed herewith.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: November 8, 2013	OFS CAPITAL CORPORATION

	By:	/s/ GLENN R. PITTSON
	Name:	Glenn R. Pittson
	Title:	Chief Executive Officer

	By:	/s/ Robert S. Palmer
		Robert S. Palmer
		Chief Financial Officer

EXHIBIT INDEX

Description

Exhibit Number
31.1		Chief Executive Officer Certification Pursuant to Exchange Act Rule 13a-14 (a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*

31.2		Chief Financial Officer Certification Pursuant to Exchange Act Rule 13a-14 (a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*

32.1		Chief Executive Officer Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*

32.2		Chief Financial Officer Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*

Filed herewith.